Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

LFMD

LifeMD Inc

Dec 12 • 04:00PM ET

3.40

-0.06 -1.73 %

Healthcare • Health Information Services • USA • NASD

Peers: HIMS CVS TDOC AMWL DOCS LFST SEM AMED EHC CHE

| Held by: VTI IWM VXF KOMP VTWO IWO PSC IWN IWC VFMF

Index	RUT	P/E	-	EPS (ttm)	-0.17	Insider Own	18.40%	Shs Outstand	46.58M	Perf Week	-2.86%
Market Cap	163.66M	Forward P/E	-	EPS next Y	-0.33	Insider Trans	-3.96%	Shs Float	39.41M	Perf Month	-32.94%
Enterprise Value	148.45M	PEG	-	EPS next Q	-0.06	Inst Own	42.89%	Short Float	12.34%	Perf Quarter	-41.68%
Income	-7.71M	P/S	0.65	EPS this Y	60.38%	Inst Trans	-8.86%	Short Ratio	4.05	Perf Half Y	-72.71%
Sales	252.34M	P/B	120.52	EPS next Y	-58.50%	ROA	-6.64%	Short Interest	4.86M	Perf YTD	-31.31%
Book/sh	0.03	P/C	6.88	EPS next 5Y	63.87%	ROE	-	52W High	15.84 -78.54%	Perf Year	-43.05%
Cash/sh	0.49	P/FCF	14.63	EPS past 3/5Y	38.43% -10.98%	ROIC	-107.57%	52W Low	3.42 -0.73%	Perf 3Y	37.10%
Dividend Est.	-	EV/EBITDA	12.69	Sales past 3/5Y	31.76% 76.32%	Gross Margin	82.23%	Volatility	4.17% 6.84%	Perf 5Y	-57.07%
Dividend TTM	-	EV/Sales	0.59	EPS Y/Y TTM	73.43%	Oper. Margin	0.27%	ATR (14)	0.25	Perf 10Y	419.48%
Dividend Ex-Date	-	Quick Ratio	0.66	Sales Y/Y TTM	30.71%	Profit Margin	-3.05%	RSI (14)	25.82	Recom	1.25
Dividend Gr. 3/5Y	- -	Current Ratio	0.73	EPS Q/Q	29.37%	SMA20	-10.98%	Beta	1.44	Target Price	9.25
Payout	-	Debt/Eq	4.98	Sales Q/Q	12.70%	SMA50	-33.61%	Rel Volume	1.09	Prev Close	3.46
Employees	336	LT Debt/Eq	4.47	Earnings	Nov 17 AMC	SMA200	-54.77%	Avg Volume	1.20M	Price	3.40
IPO	Oct 21, 2003	Option/Short	Yes / Yes	EPS/Sales Surpr.	-400.00% -3.08%	Trades		Volume	1,309,569	Change	-1.73%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-18-25	Reiterated	BTIG Research	Buy	$15 → $18
Dec-10-24	Initiated	Lake Street	Buy	$12
Dec-04-24	Initiated	Mizuho	Neutral	$7
Aug-23-24	Resumed	B. Riley Securities	Buy	$11
Jun-05-24	Initiated	KeyBanc Capital Markets	Overweight	$12
Nov-30-23	Initiated	Craig Hallum	Buy	$10
Jul-21-23	Initiated	Cantor Fitzgerald	Overweight	$7
Jul-03-23	Initiated	H.C. Wainwright	Buy	$9
Mar-10-22	Initiated	Colliers Securities	Buy	$14
Oct-04-21	Resumed	B. Riley Securities	Buy	$16

Dec-03-25 10:28AM	Hims & Hers Expands Care Scope as Prescription Platforms Evolve (Zacks)
Nov-24-25 08:00AM	LifeMD Recognized by the 2025 Deloitte Technology Fast 500 and by TIME's America's Growth Leaders of 2026 (GlobeNewswire)
Nov-20-25 11:42AM	TDOC vs. LFMD: Which Telehealth Stock Is Better for Your Portfolio? (Zacks) -7.02%
Nov-18-25 12:00AM	LifeMD Inc (LFMD) Q3 2025 Earnings Call Highlights: Strong Telehealth Growth Amidst Competitive ... (GuruFocus.com) -13.53%
Nov-17-25 05:15PM	LifeMD, Inc. (LFMD) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Loading…
04:05PM	LifeMD Reports Third Quarter 2025 Results (GlobeNewswire)
08:00AM	LifeMD to Offer Market-Leading Pricing for GLP-1 Medications Wegovy and Ozempic in Continued Collaboration with Novo Nordisk (GlobeNewswire)
Nov-14-25 06:00PM	Repare Therapeutics Inc. (RPTX) Reports Break-Even Earnings for Q3 (Zacks)
07:16AM	LifeMD Inc (LFMD) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Nov-13-25 05:15PM	Co-Diagnostics, Inc. (CODX) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -8.88%
Nov-10-25 05:10PM	Ascend Wellness Holdings, Inc. (AAWH) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
08:00AM	LifeMD to Participate in the BTIG Digital Health Forum (GlobeNewswire)
Nov-07-25 12:43PM	Hims & Hers Expands AI-Driven Personalized and Subscription-Based Care (Zacks)
Nov-05-25 05:15PM	LifeMD Reschedules Third Quarter 2025 Earnings Release and Conference Call to November 17 (GlobeNewswire) -6.57%
07:55AM	LifeMD Inc (LFMD) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
09:15AM	Loading…
Nov-04-25 09:15AM	LifeMD Divests Majority Interest in WorkSimpli Software, Positioning Company as a Pure-Play Virtual Care and Pharmacy Platform (GlobeNewswire) -5.57%
Oct-28-25 08:00AM	Labcorp Holdings (LH) Q3 Earnings Beat Estimates (Zacks)
Oct-27-25 01:50PM	HIMS vs. LFMD: Which Telehealth Stock Is the Better Investment Now? (Zacks)
Oct-24-25 09:00AM	Shareholders of LifeMD, Inc. Should Contact Levi & Korsinsky Before October 27, 2025 to Discuss Your Rights - LFMD (PR Newswire)
Oct-23-25 08:00AM	LifeMD to Report Third Quarter 2025 Financial Results on November 6 (GlobeNewswire)
Oct-22-25 08:00AM	LifeMD Names Dr. Tara Scott as Ambassador and Clinical Advisor for its Women's Health Program (GlobeNewswire)
Oct-20-25 10:06AM	HQY Expands Access With GLP-1 Telehealth & Direct HSA Platforms (Zacks)
03:58AM	LifeMD, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LFMD (PR Newswire)
Oct-17-25 09:21AM	LifeMD (LFMD) Faces Lawsuit Over Alleged Concealment of Cost and Refund Woes in Key Segments, According to Hagens Berman (PR Newswire) -5.44%
Oct-15-25 02:27PM	LifeMD (LFMD) Faces Lawsuit Over Alleged Concealment of Cost and Refund Woes in Key Segments, According to Hagens Berman (Business Wire)
Oct-10-25 09:02AM	Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman (PR Newswire) -5.59%
Oct-09-25 01:53PM	Hims & Hers Expands Personalized Care Access Via Telehealth Platform (Zacks)
12:40PM	Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman (Newsfile)
Oct-07-25 07:13AM	LifeMD, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LFMD (PR Newswire)
Oct-03-25 02:29PM	Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman (Newsfile)
08:31AM	Loading…
Oct-02-25 08:31AM	LifeMD, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LFMD (PR Newswire)
Sep-30-25 03:35PM	LifeMD Expands Novo Deal, Adds Ozempic At $499 (GuruFocus.com) +5.43%
08:00AM	LifeMD Offers Ozempic at $499 Per Month through Collaboration with Novo Nordisk (GlobeNewswire)
Sep-25-25 04:06PM	LifeMD to Participate in the ROTH 4th Annual Healthcare Opportunities Conference (GlobeNewswire)
02:44PM	Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman (Newsfile)
Sep-24-25 10:59AM	LifeMD, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights LFMD (Business Wire)
08:56AM	Survey shows 1/3 of GLP-1 users are lower-income (Investing.com)
Sep-23-25 04:05PM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire)
Sep-19-25 08:11AM	LifeMD expands pharmacy services with non-sterile compounding capabilities (TipRanks)
08:00AM	The Weight-Loss Craze Boosted The $186 Billion Telehealth Industry. What It Means For Investors. (Investor's Business Daily)
Sep-18-25 06:17PM	Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman (Newsfile) +5.76%
08:00AM	LifeMD Expands Pharmacy Services with Non-Sterile Compounding to Deliver Personalized, Cost-Efficient Therapies at Scale (GlobeNewswire)
Sep-16-25 08:45AM	LifeMD, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 25, 2025 to Discuss Your Rights - LFMD (PR Newswire)
Sep-09-25 06:24PM	Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman (PR Newswire)
07:45AM	Important Notice to Long-Term shareholders of LifeMD, Inc. (LFMD): Grabar Law Office is Investigating Claims on Your Behalf (Newsfile)
Sep-08-25 11:10AM	Hims & Hers Expanding Partnerships to Build a Global Health Ecosystem (Zacks)
Aug-28-25 08:00AM	LifeMD to Participate in Three Investor Conferences During September (GlobeNewswire)
Aug-19-25 10:01AM	Hims & Hers Fuels Growth via Market Expansion and New Care Verticals (Zacks) -6.22%
Aug-18-25 09:07AM	Novo Nordisk to offer Ozempic at $499 per month to eligible US customers (Reuters)
Aug-06-25 10:29AM	LifeMD Stock Plummets 40%. Why Weight Loss Isn't Just A Gimme. (Investor's Business Daily) -44.85%
Aug-05-25 06:05PM	LifeMD, Inc. (LFMD) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:05PM	LifeMD Reports Second Quarter 2025 Results (GlobeNewswire)
Aug-04-25 04:05PM	Medifast Announces Second Quarter 2025 Financial Results (Business Wire) +24.25%
09:59AM	LifeMD Inc (LFMD) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
08:00AM	LifeMD to Participate in the Canaccord Genuity 45th Annual Growth Conference (GlobeNewswire)
Jul-31-25 01:13PM	Hims & Hers Leads the Charge in AI-Powered Personalized Healthcare (Zacks)
08:00AM	LifeMD Names COO and Promotes Two Executives (GlobeNewswire)
Jul-29-25 04:05PM	LifeMD to Report Second Quarter 2025 Financial Results on August 5 (GlobeNewswire) -6.16%
Jul-21-25 04:05PM	Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2025 (Business Wire)
Jul-07-25 11:53AM	Health Meets Lifestyle: How Hims & Hers Is Reshaping Everyday Wellness (Zacks)
Jun-30-25 10:11AM	Hims & Hers vs. LifeMD: Which Telehealth Stock Has More Upside? (Zacks)
Jun-28-25 09:10AM	10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential (Motley Fool)
Jun-27-25 04:51AM	Novo Nordisk says WeightWatchers will sell Wegovy (Reuters Videos)
Jun-24-25 02:07PM	Teladoc (TDOC) Moves 14.4% Higher: Will This Strength Last? (Zacks)
Jun-23-25 04:05PM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire)
Jun-12-25 10:36AM	HIMS' Subscriptions Power Personalized Care & Recurring Revenue Growth (Zacks)
Jun-10-25 04:27PM	Eli Lilly telehealth deals to prevent sale of compounded GLP-1s (Yahoo Finance Video)
Jun-09-25 08:00AM	LifeMD to Participate in Two Investor Conferences During June (GlobeNewswire)
Jun-02-25 03:18PM	Solventum Stock Earns RS Rating Upgrade (Investor's Business Daily) +5.24%
May-22-25 08:05AM	LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy (GlobeNewswire) +6.78%
May-12-25 04:05PM	LifeMD to Participate in Three Investor Conferences During May (GlobeNewswire)
May-06-25 05:40PM	LifeMD, Inc. (LFMD) Q1 Earnings and Revenues Top Estimates (Zacks)
04:05PM	LifeMD Reports First Quarter 2025 Results and Raises Full-Year 2025 Guidance (GlobeNewswire)
May-05-25 10:14AM	LifeMD Inc (LFMD) Q1 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Apr-30-25 05:30AM	Why New Wegovy Deals Wont Restore Novo Nordisks Obesity Lead (The Wall Street Journal) -14.62%
Apr-29-25 03:19PM	Why Hims & Hers Health and LifeMD Are Skyrocketing Today (Motley Fool) +41.31%
10:30AM	Wegovy Today, Ozempic Tomorrow: Partnership With Novo Is Hims & Hers Comeback (Seeking Alpha)
08:05AM	LifeMD Announces Plans to Expand Affordable Access to Wegovy for Cash-Pay Patients (GlobeNewswire)
Apr-28-25 04:05PM	Medifast Announces First Quarter 2025 Financial Results (Business Wire)
04:05PM	LifeMD to Report First Quarter 2025 Financial Results on May 6 (GlobeNewswire)
08:00AM	LifeMD Acquires Women's Health Provider Optimal Human Health MD to Accelerate Entry into the Women's Health Market (GlobeNewswire)
Apr-21-25 12:52PM	LifeMD, Inc. (LFMD): A Bull Case Theory (Insider Monkey)
Apr-17-25 08:00AM	LifeMD Expands Insurance Acceptance to Medicare Beneficiaries for Qualifying Virtual Primary Care, Including in its Weight Loss Programs (GlobeNewswire) +8.05%
Apr-14-25 04:05PM	Medifast to Announce Financial Results for the First Quarter Ended March 31, 2025 (Business Wire)
Apr-09-25 08:51AM	Agilon (AGL) Moves 26.1% Higher: Will This Strength Last? (Zacks) +7.88%
Apr-08-25 10:10AM	LifeMD Is Back To Life (Seeking Alpha)
Apr-01-25 04:15PM	Hims Stock Jumps After Adding Eli Lilly's Obesity Drug To Its Platform (Investor's Business Daily)
04:02PM	Hims Stock Jumps After Inking Deal To Sell Eli Lilly's Obesity Drug, Zepbound (Investor's Business Daily)
02:30PM	Hims Stock Rockets After Inking Deal To Sell Eli Lilly's Obesity Drug, Zepbound (Investor's Business Daily)
Mar-31-25 08:00AM	LifeMD to Participate in the 24th Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-28-25 09:21AM	Medifast: GLP-1 Caused A Vicious MLM Flywheel Effect (Seeking Alpha)
Mar-25-25 04:05PM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire)
Mar-11-25 03:02AM	LifeMD Inc (LFMD) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Expansions (GuruFocus.com) +30.56%
Mar-10-25 05:30PM	LifeMD Reports Fourth Quarter 2024 Results (GlobeNewswire) -8.57%
Mar-07-25 07:06AM	LifeMD Inc (LFMD) Q4 2024: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
Mar-06-25 08:00AM	LifeMD Announces Integration with LillyDirect Pharmacy Provider to Offer Patients Streamlined Access to Branded Dual GLP-1/GIP Zepbound (GlobeNewswire)
Mar-05-25 08:00AM	LifeMD to Participate in the KeyBanc Capital Markets Healthcare Forum (GlobeNewswire)
Feb-25-25 08:05AM	LifeMD to Report Fourth Quarter 2024 Financial Results on March 10 (GlobeNewswire) -13.11%
Feb-24-25 08:05AM	LifeMD Announces Entry Into the Behavioral Health Market (GlobeNewswire)
Jan-28-25 08:00AM	LifeMD to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire) +6.80%

LifeMD, Inc. is a telehealth company, which engages in offering a portfolio of direct-to-patient products and services. The firm combines virtual medical treatment with prescription medications and over-the-counter products. It operates through the Telehealth and WorkSimpli segments. The company was founded by Justin Schreiber on May 24, 1994 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
FRIEDEMAN JESSICA	Chief Marketing Officer	Dec 09 '25	Sale	3.61	15,000	54,158	205,000	Dec 11 05:11 PM
FRIEDEMAN JESSICA	Officer	Nov 24 '25	Proposed Sale	4.04	20,000	80,800		Nov 24 12:46 PM
Alvarez Nicholas P	Chief Acquisition Officer	Sep 10 '25	Sale	5.92	75,000	443,760	605,000	Sep 12 04:32 PM
Alvarez Nicholas P	Officer	Sep 10 '25	Proposed Sale	6.12	75,000	459,000		Sep 10 10:44 AM
Schreiber Justin	Chairman and CEO	Jul 01 '25	Sale	9.99	25,000	249,690	2,475,721	Aug 05 05:14 PM
Justin Schreiber	Chairman and CEO	Aug 01 '25	Proposed Sale	10.41	175,000	1,821,750		Aug 01 04:09 PM
Schreiber Justin	Chairman and CEO	Jul 01 '25	Sale	13.38	25,000	334,458	2,500,721	Jul 03 03:53 PM
Benathen Marc David	Chief Financial Officer	Jun 16 '25	Sale	13.09	75,000	981,945	389,554	Jun 18 06:18 PM
Benathen Marc David	Chief Financial Officer	Jun 17 '25	Sale	14.01	50,000	700,495	339,554	Jun 18 06:18 PM
Yecies Eric Harold	Chief Legal Officer & GC	Jun 13 '25	Sale	12.25	15,000	183,750	16,100	Jun 17 06:12 PM
Galluppi Stefan	Chief Innovation Officer	Jun 13 '25	Sale	12.38	85,000	1,052,657	80,449	Jun 17 05:13 PM
Stefan Galluppi	Affiliate	Jun 13 '25	Proposed Sale	12.70	85,000	1,079,500		Jun 13 06:27 PM
Schreiber Justin	Chairman and CEO	Jun 02 '25	Sale	12.47	25,000	311,655	2,525,721	Jun 04 04:45 PM
Schreiber Justin	Chairman and CEO	May 01 '25	Sale	7.53	21,995	165,684	2,553,726	May 05 06:02 PM
Schreiber Justin	Chairman and CEO	May 02 '25	Sale	7.50	3,005	22,539	2,550,721	May 05 06:02 PM
Schreiber Justin	Chairman and CEO	Apr 29 '25	Sale	7.78	50,000	389,040	2,575,721	May 01 04:47 PM
Justin Schreiber	Chairman and CEO	Apr 29 '25	Proposed Sale	8.05	125,000	1,006,250		Apr 29 04:19 PM
FRIEDEMAN JESSICA	Chief Marketing Officer	Mar 14 '25	Sale	5.66	30,000	169,665	170,000	Mar 17 06:36 PM
Schreiber Justin	Chief Executive Officer	Feb 14 '25	Sale	7.55	50,000	377,620	2,653,715	Feb 21 05:34 PM
Schreiber Justin	Chief Executive Officer	Jan 02 '25	Sale	5.19	25,000	129,668	2,703,715	Jan 06 05:33 PM

Open in Screener

TDOC

Teladoc Health Inc

Dec 12 • 04:00PM ET

7.55

-0.07 -0.92 %

Healthcare • Health Information Services • USA • NYSE

TDOC Teladoc Health Inc daily Stock Chart

Peers: AMWL DOCS TVRD HIMS GDRX CLOV OSCR ACHC MD RMTI

| Held by: VTI VB IWM VBK VXF AVUV IWN VTWO DFAT SCHA

Index	RUT	P/E	-	EPS (ttm)	-1.28	Insider Own	1.11%	Shs Outstand	177.35M	Perf Week	-0.53%
Market Cap	1.34B	Forward P/E	-	EPS next Y	-0.83	Insider Trans	-3.98%	Shs Float	175.51M	Perf Month	1.07%
Enterprise Value	1.66B	PEG	-	EPS next Q	-0.18	Inst Own	70.48%	Short Float	14.65%	Perf Quarter	-1.56%
Income	-223.59M	P/S	0.53	EPS this Y	79.92%	Inst Trans	-2.56%	Short Ratio	3.44	Perf Half Y	10.06%
Sales	2.53B	P/B	0.96	EPS next Y	29.63%	ROA	-6.98%	Short Interest	25.72M	Perf YTD	-16.94%
Book/sh	7.85	P/C	1.84	EPS next 5Y	51.47%	ROE	-15.42%	52W High	15.21 -50.36%	Perf Year	-28.77%
Cash/sh	4.09	P/FCF	4.85	EPS past 3/5Y	-29.04% -33.66%	ROIC	-9.22%	52W Low	6.35 18.90%	Perf 3Y	-70.85%
Dividend Est.	-	EV/EBITDA	8.70	Sales past 3/5Y	8.13% 35.95%	Gross Margin	55.61%	Volatility	3.41% 4.06%	Perf 5Y	-96.17%
Dividend TTM	-	EV/Sales	0.65	EPS Y/Y TTM	77.85%	Oper. Margin	-7.06%	ATR (14)	0.32	Perf 10Y	-63.84%
Dividend Ex-Date	-	Quick Ratio	2.52	Sales Y/Y TTM	-2.37%	Profit Margin	-8.84%	RSI (14)	48.69	Recom	2.64
Dividend Gr. 3/5Y	- -	Current Ratio	2.61	EPS Q/Q	-44.23%	SMA20	2.62%	Beta	2.04	Target Price	9.08
Payout	-	Debt/Eq	0.75	Sales Q/Q	-2.20%	SMA50	-5.31%	Rel Volume	0.46	Prev Close	7.62
Employees	5500	LT Debt/Eq	0.74	Earnings	Oct 29 AMC	SMA200	-2.99%	Avg Volume	7.48M	Price	7.55
IPO	Jul 01, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	-6.22% 0.11%	Trades		Volume	3,450,815	Change	-0.92%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-09-25	Initiated	Barclays	Equal Weight	$8.50
Nov-13-25	Initiated	BMO Capital Markets	Market Perform	$8
Jul-25-25	Initiated	Mizuho	Neutral	$10
Nov-15-24	Initiated	Goldman	Buy	$14
Sep-17-24	Reiterated	Jefferies	Hold	$8 → $10
Feb-29-24	Initiated	Cantor Fitzgerald	Overweight	$22
Feb-26-24	Initiated	Leerink Partners	Market Perform	$17
Jan-17-24	Downgrade	DA Davidson	Buy → Neutral	$33 → $22
Jan-03-24	Initiated	Barclays	Overweight	$26
Apr-12-23	Initiated	Stephens	Equal-Weight	$25
Feb-23-23	Upgrade	SVB Securities	Market Perform → Outperform	$34
Oct-24-22	Upgrade	Guggenheim	Sell → Neutral
Sep-16-22	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-07-22	Initiated	Truist	Hold	$35
Aug-17-22	Downgrade	Guggenheim	Neutral → Sell	$25
Aug-12-22	Initiated	DA Davidson	Buy	$45
Aug-02-22	Downgrade	Cowen	Outperform → Market Perform	$58 → $34
Aug-02-22	Downgrade	Berenberg	Buy → Hold	$35
Jul-28-22	Downgrade	Needham	Buy → Hold
Jul-28-22	Downgrade	Goldman	Buy → Neutral	$55 → $36

Show Previous Ratings

Today 11:35AM	Private Markets: Musks SpaceX targets 2026 IPO at valuation of $1.5T (TipRanks)
07:13AM	Forget Teladoc and Buy This Healthcare Stock Instead (Motley Fool)
Dec-11-25 10:32AM	Hims & Hers Expands Its Technology-Driven Personalized Virtual Care (Zacks)
Dec-09-25 11:25AM	Hims & Hers Plunges 29.1% in 6 Months: Time to Hold the Stock or Sell? (Zacks)
Dec-01-25 05:57AM	3 Unprofitable Stocks We Approach with Caution (StockStory)
11:30AM	Loading…
Nov-28-25 11:30AM	Why Is Teladoc (TDOC) Down 14.8% Since Last Earnings Report? (Zacks)
Nov-26-25 04:05PM	Teladoc Health to Participate in Upcoming Investor Conference (GlobeNewswire)
Nov-24-25 04:55PM	Teladoc, Angi, Upwork, and ACV Auctions Shares Are Soaring, What You Need To Know (StockStory)
Nov-21-25 11:06AM	Does Teladoc's Acquisition Strategy Boost Growth and Global Footprint? (Zacks)
Nov-20-25 04:55PM	Teladoc and Netflix Shares Are Falling, What You Need To Know (StockStory)
11:42AM	TDOC vs. LFMD: Which Telehealth Stock Is Better for Your Portfolio? (Zacks)
Nov-19-25 10:32PM	Online Marketplace Stocks Q3 Highlights: Teladoc (NYSE:TDOC) (StockStory)
12:24PM	TDOC Partners With TytoCare to Expand At-Home Exam Capabilities (Zacks)
Nov-18-25 11:43AM	Hims & Hers Plunges 15.6% in 3 Months: Time to Hold the Stock or Sell? (Zacks)
09:00AM	TytoCare Integrates With Teladoc Health to Augment Virtual Primary and Urgent Care (PR Newswire)
11:23AM	Loading…
Nov-17-25 11:23AM	Is Teladoc Health Accelerating Growth Through Global Expansion? (Zacks)
Nov-15-25 11:42PM	Teladoc Health Held In-Line Rating in Late Ocotber as Evercore Reversed Price Target Back to $8 (Insider Monkey)
Nov-13-25 03:55PM	Teladoc, MercadoLibre, Reddit, Lyft, and Wayfair Stocks Trade Down, What You Need To Know (StockStory) -5.35%
Nov-11-25 01:26PM	Teladoc Health's Q3 Loss Widens Y/Y on Weak BetterHelp Unit (Zacks)
12:43PM	Hims & Hers Scales Technology-Enabled, Vertically Integrated Care (Zacks)
Nov-10-25 12:47PM	How is Teladoc Health Placed in the Growing Telemedicine Market? (Zacks)
Nov-06-25 04:30PM	Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08 (GlobeNewswire) -5.46%
01:31PM	1 Russell 2000 Stock to Keep an Eye On and 2 Facing Challenges (StockStory)
Nov-05-25 12:23PM	How to Play Teladoc Health Stock Post Q3 Results: Buy, Hold or Sell? (Zacks)
06:45AM	Why Teladoc Stock Zoomed Almost 12% Higher in October (Motley Fool)
12:32AM	The 5 Most Interesting Analyst Questions From Teladoc's Q3 Earnings Call (StockStory)
Nov-04-25 11:42AM	Sovato raises Series B funds to advance remote robotic surgery platform (Medical Device Network)
Nov-03-25 09:24PM	Is This Beaten-Down Stock Finally on the Road to Recovery? (Motley Fool) -5.68%
04:01PM	Why Teladoc (TDOC) Shares Are Getting Obliterated Today (StockStory)
Oct-31-25 07:38AM	Harry Yous Berto Embraces Clinic-in-a-Box with OnMed Event Flash (Exec Edge)
06:54PM	Loading…
Oct-30-25 06:54PM	Teladoc Finds Its Groove With Strong Q3, AI Push (GuruFocus.com) +6.20%
04:11PM	Teladoc Health Inc (TDOC) Q3 2025 Earnings Call Highlights: Navigating Challenges and Seizing ... (GuruFocus.com)
02:35PM	Why Teladoc (TDOC) Stock Is Trading Up Today (StockStory)
09:16AM	TDOC Q3 CY2025 Deep Dive: Insurance Pivot, International Growth, and Margin Pressures (StockStory)
09:00AM	Teladoc expands insurance coverage at mental health unit BetterHelp (Healthcare Dive)
Oct-29-25 07:00PM	Teladoc (TDOC) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
05:45PM	Teladoc (TDOC) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
04:45PM	Teladoc: Q3 Earnings Snapshot (Associated Press Finance)
04:27PM	Teladoc's (NYSE:TDOC) Q3 Earnings Results: Revenue In Line With Expectations (StockStory)
04:05PM	Teladoc Health Reports Third Quarter 2025 Results (GlobeNewswire)
Oct-28-25 09:15AM	Wall Street's Insights Into Key Metrics Ahead of Teladoc (TDOC) Q3 Earnings (Zacks) -7.21%
07:45AM	GeneDx Holdings Corp. (WGS) Q3 Earnings and Revenues Surpass Estimates (Zacks)
Oct-27-25 11:04PM	Teladoc (TDOC) Q3 Earnings Report Preview: What To Look For (StockStory)
11:44AM	Teladoc (TDOC) Soars 10.0%: Is Further Upside Left in the Stock? (Zacks)
Oct-24-25 04:25PM	Teladoc, Robinhood, and Reddit Shares Skyrocket, What You Need To Know (StockStory) +10.00%
05:58AM	Teladoc finance chief to step down (Healthcare Dive)
Oct-23-25 04:05PM	Teladoc Health Announces Chief Financial Officer Transition (GlobeNewswire)
11:29AM	Stock Market Today: Quantum Computing Stocks Take Center Stage After Trump Bombshell (TheStreet)
10:00AM	Organon (OGN) Earnings Expected to Grow: Should You Buy? (Zacks)
Oct-22-25 10:00AM	Teladoc (TDOC) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Oct-17-25 06:15PM	Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know (Zacks) -5.43% +5.28%
10:18AM	Danaher Gears Up to Post Q3 Earnings: What Lies Ahead for the Stock? (Zacks)
06:17AM	Better Beaten-Down Stock: Iovance Biotherapeutics vs. Teladoc Health (Motley Fool)
Oct-16-25 12:36PM	Hims & Hers Elevates Technology-Driven Healthcare Accessibility (Zacks)
08:50AM	How to Find Strong Medical Stocks Slated for Positive Earnings Surprises (Zacks)
03:23AM	Zacks.com featured highlights include United Natural Foods, Teladoc Health, Supernus and BRP (Zacks)
12:01AM	3 Reasons TDOC is Risky and 1 Stock to Buy Instead (StockStory)
Oct-15-25 04:30PM	Teladoc Health to Announce Third Quarter 2025 Financial Results (GlobeNewswire)
03:08PM	Can 4 Relative Price Strength Stocks Defy Market Swings? (Zacks)
09:35AM	Teladoc (TDOC) Recently Broke Out Above the 20-Day Moving Average (Zacks)
09:30AM	Teladoc (TDOC) Just Reclaimed the 200-Day Moving Average (Zacks)
09:17AM	Teladoc Health Expands Clarity Platform With Workplace Safety Tool (Zacks)
08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
08:50AM	Looking for a Fast-paced Momentum Stock at a Bargain? Consider Teladoc (TDOC) (Zacks)
Oct-14-25 01:13PM	Hims & Hers Gains 3.8% in 3 Months: Time to Hold the Stock or Sell? (Zacks) +8.24%
01:06PM	Why Teladoc (TDOC) Stock Is Trading Up Today (StockStory)
06:00AM	Teladoc Health Adds Workplace Safety Capability to its AI-Enabled Clarity Monitoring Solution for Hospitals and Health Systems (GlobeNewswire)
Oct-10-25 11:50AM	3 Medical Service Industry Stocks Poised to Counter Workforce Issues (Zacks) -9.60%
Oct-08-25 11:36AM	Why Is Teladoc (TDOC) Stock Soaring Today (StockStory) +8.60%
Oct-07-25 11:35PM	Online Marketplace Stocks Q2 In Review: Teladoc (NYSE:TDOC) Vs Peers (StockStory)
03:25PM	Teladoc and Uber Stocks Trade Down, What You Need To Know (StockStory)
09:40AM	Is Progyny (PGNY) Stock Undervalued Right Now? (Zacks)
Oct-06-25 06:15PM	Teladoc (TDOC) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
12:00PM	All You Need to Know About Teladoc (TDOC) Rating Upgrade to Buy (Zacks)
08:20AM	Strength Seen in Teladoc (TDOC): Can Its 6.3% Jump Turn into More Strength? (Zacks)
Oct-03-25 01:05PM	Why Teladoc Health Stock Jumped 15% This Morning (Motley Fool) +6.25%
01:30AM	Short Sellers Survive a Tough Tape, Believing Their Day Will Come (Barrons.com)
Oct-01-25 07:15AM	Down 96% From Its Highs, Is Teladoc a Hidden Bargain or a Value Trap? (Motley Fool)
Sep-30-25 10:05AM	OptimizeRx Bets on AI and Workflow Integration - Will This Pay Off? (Zacks) -5.73%
Sep-26-25 10:21AM	Just How Healthy Is the Business of Mental Health? (Barrons.com)
10:09AM	The Stock Market Is Up, but the Dollar Is Down. What It Means for You. (Barrons.com)
Sep-23-25 06:15PM	Teladoc (TDOC) Rises As Market Takes a Dip: Key Facts (Zacks)
01:50PM	Why Is Teladoc (TDOC) Stock Soaring Today (StockStory)
Sep-19-25 05:30PM	Healthcare stocks: Why you should buy Doximity, not Teladoc (Yahoo Finance Video)
Sep-16-25 06:15PM	Teladoc (TDOC) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
10:23AM	Hims & Hers Expands AI and Technology Focus to Advance Digital Care (Zacks)
Sep-12-25 10:02AM	Hims & Hers Surges 64.1% in 6 Months: How to Play the Stock? (Zacks)
Sep-10-25 06:15PM	Teladoc (TDOC) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
Sep-05-25 09:30AM	2 Beaten-Down Stocks to Avoid Right Now (Motley Fool)
Sep-02-25 12:40AM	1 Cash-Producing Stock on Our Buy List and 2 We Find Risky (StockStory)
Aug-28-25 11:30AM	Why Is Teladoc (TDOC) Up 4.6% Since Last Earnings Report? (Zacks)
12:32AM	3 Stocks Under $10 That Fall Short (StockStory)
Aug-27-25 10:44AM	Hims & Hers Scales Growth Through Subscriptions and Care Expansion (Zacks)
Aug-25-25 07:00PM	Teladoc: A Telehealth Titan in Trouble? (Motley Fool)
Aug-18-25 10:47AM	Teladoc Health expands in Australia with Telecare acquisition (Hospital Management)
05:40AM	Teladoc acquires Australian virtual care firm Telecare (Healthcare Dive)
12:34AM	1 of Wall Street's Favorite Stock Worth Your Attention and 2 We Turn Down (StockStory)
Aug-15-25 01:55PM	Why Teladoc (TDOC) Stock Is Trading Up Today (StockStory)
Aug-14-25 05:00PM	Teladoc Health Acquires Telecare, Expanding Access to Specialist and Allied Health Care for Australians in Public and Private Health (GlobeNewswire)
Aug-13-25 12:43PM	Hims & Hers Stock Plunges 21.3% in 3 Months: Time to Hold or Exit? (Zacks) +8.30%

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DIVITA CHARLES III	CHIEF EXECUTIVE OFFICER	Dec 11 '25	Sale	7.63	17,138	130,837	201,036	Dec 11 04:23 PM
DIVITA CHARLES III	Officer	Dec 11 '25	Proposed Sale	7.63	17,138	130,837		Dec 11 03:46 PM
Rodrigues Fernando M.	President of BetterHelp	Dec 03 '25	Sale	7.48	4,209	31,483	0	Dec 03 09:04 PM
Rodrigues Fernando M.	President of BetterHelp	Dec 02 '25	Sale	7.49	2,324	17,402	4,209	Dec 03 09:04 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Dec 02 '25	Sale	7.49	5,720	42,831	80,732	Dec 03 09:04 PM
Nueno Carlos	President, International	Dec 02 '25	Sale	7.49	3,897	29,181	27,175	Dec 03 09:03 PM
Bliss Kelly	President, U.S. Group Health	Dec 02 '25	Sale	7.49	4,582	34,310	60,054	Dec 03 09:03 PM
Rodrigues Fernando M.	Officer	Dec 03 '25	Proposed Sale	7.48	4,209	31,483		Dec 03 09:46 AM
Vandervoort Adam C	Officer	Dec 02 '25	Proposed Sale	7.49	5,720	42,833		Dec 02 04:25 PM
Nueno Carlos	Officer	Dec 02 '25	Proposed Sale	7.49	3,897	29,182		Dec 02 04:22 PM
Bliss Kelly	Officer	Dec 02 '25	Proposed Sale	7.49	4,582	34,311		Dec 02 04:15 PM
Rodrigues Fernando M.	Officer	Dec 02 '25	Proposed Sale	7.49	2,324	17,403		Dec 02 04:14 PM
Paulus Kenneth H	Director	Nov 14 '25	Buy	6.94	10,000	69,400	10,000	Nov 17 04:05 PM
Catapano Joseph Ronald	Chief Accounting Officer	Oct 02 '25	Sale	7.88	2,972	23,434	5,361	Oct 03 04:05 PM
DIVITA CHARLES III	CHIEF EXECUTIVE OFFICER	Sep 11 '25	Sale	7.59	16,787	127,435	179,014	Sep 11 04:04 PM
DIVITA CHARLES III	Officer	Sep 11 '25	Proposed Sale	7.59	16,787	127,435		Sep 11 03:28 PM
Rodrigues Fernando M.	President of BetterHelp	Sep 03 '25	Sale	7.59	4,149	31,491	0	Sep 03 04:05 PM
Rodrigues Fernando M.	President of BetterHelp	Sep 02 '25	Sale	7.58	2,383	18,075	4,149	Sep 03 04:05 PM
Nueno Carlos	President, International	Sep 02 '25	Sale	7.58	3,998	30,325	22,359	Sep 03 04:05 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Sep 02 '25	Sale	7.58	5,867	44,501	75,179	Sep 03 04:05 PM
Bliss Kelly	President, U.S. Group Health	Sep 02 '25	Sale	7.58	4,700	35,650	55,101	Sep 03 04:05 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Sep 02 '25	Sale	7.58	12,846	97,437	142,385	Sep 03 04:05 PM
Rodrigues Fernando M.	Officer	Sep 03 '25	Proposed Sale	7.59	4,149	31,491		Sep 03 11:45 AM
Rodrigues Fernando M.	Officer	Sep 02 '25	Proposed Sale	7.59	2,383	18,076		Sep 02 04:33 PM
Bliss Kelly	Officer	Sep 02 '25	Proposed Sale	7.59	4,700	35,651		Sep 02 04:15 PM
Nueno Carlos	Officer	Sep 02 '25	Proposed Sale	7.59	3,998	30,326		Sep 02 04:09 PM
Vandervoort Adam C	Officer	Sep 02 '25	Proposed Sale	7.59	5,867	44,503		Sep 02 04:05 PM
Murthy Mala	Officer	Sep 02 '25	Proposed Sale	7.59	12,846	97,441		Sep 02 03:59 PM
Rodrigues Fernando M.	President of BetterHelp	Jun 03 '25	Sale	6.91	4,174	28,842	0	Jun 03 05:37 PM
Rodrigues Fernando M.	President of BetterHelp	Jun 02 '25	Sale	6.86	2,358	16,176	4,174	Jun 03 05:37 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Jun 02 '25	Sale	6.86	5,808	39,843	69,773	Jun 03 05:37 PM
Bliss Kelly	President, U.S. Group Health	Jun 02 '25	Sale	6.86	4,653	31,920	50,266	Jun 03 05:36 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Jun 02 '25	Sale	6.86	13,856	95,052	132,443	Jun 03 05:36 PM
Nueno Carlos	President, International	Jun 02 '25	Sale	6.86	3,958	27,152	17,645	Jun 03 05:36 PM
Rodrigues Fernando M.	Officer	Jun 03 '25	Proposed Sale	6.91	4,174	28,842		Jun 03 10:53 AM
Murthy Mala	Officer	Jun 02 '25	Proposed Sale	6.86	13,856	95,052		Jun 02 03:46 PM
Rodrigues Fernando M.	Officer	Jun 02 '25	Proposed Sale	6.86	2,358	16,176		Jun 02 03:45 PM
Vandervoort Adam C	Officer	Jun 02 '25	Proposed Sale	6.86	5,808	39,843		Jun 02 03:44 PM
Bliss Kelly	Officer	Jun 02 '25	Proposed Sale	6.86	4,653	31,920		Jun 02 03:43 PM
Nueno Carlos	Officer	Jun 02 '25	Proposed Sale	6.86	3,958	27,152		Jun 02 03:38 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Apr 07 '25	Sale	6.81	7,494	51,012	121,467	Apr 08 04:23 PM
Murthy Mala	Officer	Apr 07 '25	Proposed Sale	6.81	7,494	51,012		Apr 07 05:15 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Mar 20 '25	Sale	8.42	20,586	173,416	116,309	Mar 21 04:20 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Mar 20 '25	Sale	8.42	11,011	92,757	64,308	Mar 21 04:20 PM
Rodrigues Fernando M.	President of BetterHelp	Mar 21 '25	Sale	8.00	2,663	21,304	0	Mar 21 04:19 PM
Rodrigues Fernando M.	President of BetterHelp	Mar 20 '25	Sale	8.42	1,503	12,661	2,663	Mar 21 04:19 PM
Bliss Kelly	President, U.S. Group Health	Mar 20 '25	Sale	8.42	9,470	79,775	45,384	Mar 21 04:19 PM
Nueno Carlos	President, International	Mar 20 '25	Sale	8.42	8,266	69,633	12,891	Mar 21 04:19 PM
Rodrigues Fernando M.	Officer	Mar 21 '25	Proposed Sale	8.00	2,663	21,304		Mar 21 10:16 AM
Rodrigues Fernando M.	Officer	Mar 20 '25	Proposed Sale	8.42	1,503	12,661		Mar 20 03:25 PM
Bliss Kelly	Officer	Mar 20 '25	Proposed Sale	8.42	9,470	79,773		Mar 20 03:13 PM
Murthy Mala	Officer	Mar 20 '25	Proposed Sale	8.42	20,586	173,412		Mar 20 03:12 PM
Vandervoort Adam C	Officer	Mar 20 '25	Proposed Sale	8.42	11,011	92,754		Mar 20 03:10 PM
Nueno Carlos	Officer	Mar 20 '25	Proposed Sale	8.42	8,266	69,631		Mar 20 03:09 PM
Rodrigues Fernando M.	President of BetterHelp	Mar 05 '25	Sale	9.20	3,558	32,734	0	Mar 06 04:04 PM
Rodrigues Fernando M.	Officer	Mar 05 '25	Proposed Sale	9.20	3,558	32,734		Mar 05 09:44 AM
Rodrigues Fernando M.	President of BetterHelp	Mar 03 '25	Sale	9.68	1,933	18,719	3,558	Mar 04 04:07 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Mar 03 '25	Sale	9.68	8,630	83,573	99,962	Mar 04 04:07 PM
Nueno Carlos	President, International	Mar 03 '25	Sale	9.68	2,347	22,728	2,932	Mar 04 04:06 PM
Bliss Kelly	President, U.S. Group Health	Mar 03 '25	Sale	9.68	2,904	28,122	35,421	Mar 04 04:06 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Mar 03 '25	Sale	9.68	3,935	38,107	53,919	Mar 04 04:06 PM
Bliss Kelly	Officer	Mar 03 '25	Proposed Sale	9.68	2,904	28,124		Mar 03 04:29 PM
Murthy Mala	Officer	Mar 03 '25	Proposed Sale	9.68	8,630	83,576		Mar 03 04:22 PM
Nueno Carlos	Officer	Mar 03 '25	Proposed Sale	9.68	2,347	22,729		Mar 03 04:21 PM
Rodrigues Fernando M.	Officer	Mar 03 '25	Proposed Sale	9.68	1,933	18,720		Mar 03 04:20 PM
Vandervoort Adam C	Officer	Mar 03 '25	Proposed Sale	9.68	3,935	38,108		Mar 03 04:17 PM
Nanis Nikolaos P.	Officer	Jan 03 '25	Proposed Sale	9.33	502	4,681		Jan 03 05:31 PM
Waters Michael Willem	Officer	Dec 16 '24	Proposed Sale	10.28	4,652	47,823		Dec 16 10:46 AM

HIMS Hims & Hers Health Inc daily Stock Chart

Peers: ELF LFMD PRGO TDOC GDRX AMWL DOCS CLOV RXRX TWST

| Held by: VTI IJH VB IWM VBK VXF IWO XMHQ XMMO MDY

Index	RUT	P/E	68.79	EPS (ttm)	0.54	Insider Own	10.09%	Shs Outstand	219.12M	Perf Week	-5.08%
Market Cap	8.47B	Forward P/E	62.19	EPS next Y	0.60	Insider Trans	-8.26%	Shs Float	204.67M	Perf Month	-4.64%
Enterprise Value	8.96B	PEG	5.08	EPS next Q	0.05	Inst Own	89.50%	Short Float	32.90%	Perf Quarter	-31.04%
Income	133.79M	P/S	3.83	EPS this Y	-11.46%	Inst Trans	14.41%	Short Ratio	2.56	Perf Half Y	-32.93%
Sales	2.21B	P/B	14.57	EPS next Y	27.49%	ROA	9.44%	Short Interest	67.33M	Perf YTD	53.89%
Book/sh	2.55	P/C	13.45	EPS next 5Y	12.25%	ROE	26.21%	52W High	72.98 -49.01%	Perf Year	20.54%
Cash/sh	2.77	P/FCF	72.97	EPS past 3/5Y	- 17.22%	ROIC	7.89%	52W Low	23.97 55.24%	Perf 3Y	431.57%
Dividend Est.	-	EV/EBITDA	51.41	Sales past 3/5Y	75.77% -	Gross Margin	65.40%	Volatility	4.56% 6.17%	Perf 5Y	214.81%
Dividend TTM	-	EV/Sales	4.05	EPS Y/Y TTM	28.15%	Oper. Margin	5.96%	ATR (14)	2.37	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.64	Sales Y/Y TTM	78.02%	Profit Margin	6.05%	RSI (14)	42.74	Recom	2.72
Dividend Gr. 3/5Y	- -	Current Ratio	1.88	EPS Q/Q	-80.29%	SMA20	-0.50%	Beta	2.35	Target Price	47.75
Payout	0.00%	Debt/Eq	1.92	Sales Q/Q	49.16%	SMA50	-15.83%	Rel Volume	0.39	Prev Close	37.77
Employees	1637	LT Debt/Eq	1.92	Earnings	Nov 03 AMC	SMA200	-18.91%	Avg Volume	26.30M	Price	37.21
IPO	Sep 13, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	-36.37% 3.23%	Trades		Volume	10,249,871	Change	-1.48%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-09-25	Initiated	Barclays	Overweight	$48
Oct-21-25	Initiated	KeyBanc Capital Markets	Sector Weight
Jun-23-25	Downgrade	Needham	Buy → Hold
Jun-04-25	Reiterated	Needham	Buy	$61 → $65
Apr-29-25	Downgrade	TD Cowen	Buy → Hold	$30
Feb-18-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$42 → $60
Jan-10-25	Downgrade	Citigroup	Neutral → Sell	$24 → $25
Jan-07-25	Initiated	BTIG Research	Buy	$35
Dec-17-24	Initiated	Morgan Stanley	Overweight	$42
Nov-14-24	Downgrade	BofA Securities	Buy → Underperform
Aug-22-24	Initiated	Needham	Buy	$24
Aug-09-24	Downgrade	Imperial Capital	Outperform → In-line
May-22-24	Downgrade	Citigroup	Buy → Neutral	$16 → $20
Apr-16-24	Downgrade	Jefferies	Buy → Hold	$17 → $15
Apr-10-24	Initiated	Canaccord Genuity	Buy	$20
Feb-28-24	Upgrade	Imperial Capital	In-line → Outperform	$16
Feb-26-24	Initiated	Leerink Partners	Market Perform	$10
Dec-07-23	Initiated	Imperial Capital	In-line	$9
Jul-28-23	Initiated	TD Cowen	Outperform	$11
Apr-11-23	Initiated	Robert W. Baird	Neutral	$10

Show Previous Ratings

Dec-12-25 09:38AM	Hims & Hers Expands Weight-Management Program to the United Kingdom (Zacks)
09:00AM	Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know (Zacks)
Dec-11-25 10:32AM	Hims & Hers Expands Its Technology-Driven Personalized Virtual Care (Zacks)
01:15AM	Novo Nordisk Is Trading as If Obesity Drug Craze Never Happened (Bloomberg)
Dec-10-25 04:15PM	Hims stock falls after lawmakers propose GLP-1 compounding restrictions (Investing.com)
07:37AM	Loading…
07:37AM	Is TEM Stock a Buy, Hold, or Sell During Its Pivotal Transition? (Zacks)
06:34AM	Hims & Hers Expands Weight Loss Program to the U.K. (GuruFocus.com)
03:30AM	Hims & Hers Brings Comprehensive Weight Loss Programme to the UK (Business Wire)
Dec-09-25 11:25AM	Hims & Hers Plunges 29.1% in 6 Months: Time to Hold the Stock or Sell? (Zacks)
09:32AM	5 High Short-Interest Stocks to Buy Before Q1 2026 (MarketBeat)
Dec-08-25 11:40AM	OMCL vs. HIMS: Which Stock Should Value Investors Buy Now? (Zacks)
Dec-05-25 08:44AM	Tempus AI Boosts Its Clinical AI Capabilities Through Strategic Moves (Zacks)
07:59AM	Wegovy's prices are going down, but they are 'wildly different' (MarketWatch)
Dec-04-25 11:39PM	2 Cash-Producing Stocks to Keep an Eye On and 1 That Underwhelm (StockStory) +7.96%
04:18PM	Stocks to Watch Thursday: Salesforce, Meta, Kroger, Dollar General (The Wall Street Journal)
11:46AM	Loading…
11:46AM	HIMS Stock Jumps After Buyout Deal, Boosts Blood Collection Efficiency (Zacks)
11:41AM	Hims & Hers Targets Canadian Obesity Crisis in Bold Weight-Loss Push with Semaglutide Tailwind (GuruFocus.com)
11:16AM	Hims & Hers Health, Inc. (HIMS): A Bull Case Theory (Insider Monkey)
11:06AM	Hims & Hers Stock Gains on Move Into Canada (The Wall Street Journal)
10:15AM	The Three Moves Hims & Hers Made This Week To Bolster Its Weight-Loss Biz (Investor's Business Daily)
07:00AM	Hims & Hers Now Serving Customers in Canada (Business Wire)
07:00AM	Hims & Hers Continues Major International Expansion With Official Entry Into Canada (Business Wire)
04:59AM	Hims & Hers Health signs agreement to acquire YourBio Health (Medical Device Network)
Dec-03-25 11:30AM	Hims & Hers Health (HIMS) Down 15.1% Since Last Earnings Report: Can It Rebound? (Zacks)
10:28AM	Hims & Hers Expands Care Scope as Prescription Platforms Evolve (Zacks)
09:00AM	Hims & Hers to Acquire YourBio Health, Pioneer Behind Advanced, Pain-Free Blood Sampling Technology (Business Wire)
Dec-01-25 09:00AM	Here is What to Know Beyond Why Hims & Hers Health, Inc. (HIMS) is a Trending Stock (Zacks) -5.66%
Nov-28-25 12:38PM	HIMS vs. GDRX: Which Consumer Health Stock Offers Greater Upside? (Zacks)
Nov-25-25 12:28PM	Hims & Hers Expands Care Scope as Digital Health Platforms Evolve (Zacks)
Nov-24-25 05:32PM	Hims, Block, and NRG Just Launched Huge Stock Buybacks (MarketBeat) +8.84%
11:33PM	Loading…
Nov-23-25 11:33PM	1 Small-Cap Stock with Exciting Potential and 2 We Avoid (StockStory)
Nov-22-25 07:00AM	MarketBeat Week in Review - 11/17 - 11/21 (MarketBeat)
Nov-21-25 10:54AM	Hims & Hers Accelerates Its Clinician-Led, Platform-Driven Care Model (Zacks)
Nov-20-25 11:40AM	OMCL or HIMS: Which Is the Better Value Stock Right Now? (Zacks) -6.17%
Nov-19-25 05:27PM	HIMS Has Been a Roller Coaster Ride. Should Investors Hop On? (MarketBeat)
Nov-18-25 11:43AM	Hims & Hers Plunges 15.6% in 3 Months: Time to Hold the Stock or Sell? (Zacks)
09:00AM	Is Trending Stock Hims & Hers Health, Inc. (HIMS) a Buy Now? (Zacks)
Nov-17-25 04:44PM	How Novo Nordisk Just Undercut Eli Lilly And The Trump Administration (Investor's Business Daily)
02:11PM	Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today (StockStory)
08:56AM	Novo Nordisk Cuts Prices for Obesity Drugs (The Wall Street Journal)
08:00AM	Hims & Hers Health, Inc. Announces $250 Million Share Repurchase Program Authorization (Business Wire)
06:00AM	Hims & Hers Names Deb Autor as Chief Policy Officer to Lead Global Policy and Regulatory Strategy (Business Wire)
Nov-13-25 11:40PM	1 Healthcare Stock to Consider Right Now and 2 Facing Headwinds (StockStory) -7.61%
12:00PM	Hims & Hers Introduces Labs, a Holistic, In-Depth Testing Experience That Puts Customers in Control of Their Health and Wellness Journeys (Business Wire)
11:49AM	Hims & Hers Bets on Lab Testing to Boost Growth (The Wall Street Journal)
08:15AM	2 Strong Healthcare Stock Picks for Growth Investors (Motley Fool)
04:40AM	2 Quality Healthcare Stocks That Could Build a Strong Foundation for Beginner Investors (Motley Fool)
Nov-12-25 08:39AM	Huge Opportunity to Buy These 4 Stocks (Motley Fool)
06:55AM	Consumer discretionary is the most-shorted sector amid concern about the U.S. economy (MarketWatch)
Nov-11-25 10:31PM	Healthcare Technology Stocks Q3 Teardown: Hims & Hers Health (NYSE:HIMS) Vs The Rest (StockStory)
12:43PM	Hims & Hers Scales Technology-Enabled, Vertically Integrated Care (Zacks)
05:30AM	Obesity Drugs Are About to Go Mass-Market (The Wall Street Journal)
Nov-10-25 12:31AM	Hims & Hers Health's Q3 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Nov-09-25 04:35AM	Hims & Hers Revenue Continues to Surge. Is It Time to Buy the Stock? (Motley Fool)
Nov-07-25 12:43PM	Hims & Hers Expands AI-Driven Personalized and Subscription-Based Care (Zacks)
09:00AM	Is Most-Watched Stock Hims & Hers Health, Inc. (HIMS) Worth Betting on Now? (Zacks)
08:02AM	The Weight-Loss Drugs Craze Is Going Strong. But Stock Investors Should Know A Few Things. (Investor's Business Daily)
Nov-05-25 04:31PM	Novo Nordisk CFO On Metsera, Hims And Lilly, And Why 'Hyper Growth' Has Stalled (Investor's Business Daily) -5.05%
12:26PM	Why Are Hims & Hers Health (HIMS) Shares Soaring Today (StockStory)
12:12PM	Hims & Hers Stock Slips Post Y/Y Q3 Earnings Decline, Margins Contract (Zacks)
10:41AM	Why Hims & Hers Stock May Be a Buy After Mixed Q3 Results (MarketBeat)
Nov-04-25 07:11PM	Analyst Report: Hims & Hers Health, Inc. (Morningstar Research)
04:17PM	Hims Says It's Negotiating A New Deal With Novo Nordisk, But Shares Slide (Investor's Business Daily)
11:40AM	OMCL vs. HIMS: Which Stock Is the Better Value Option? (Zacks)
10:51AM	Hims & Hers Eyes Major Weight-Loss Breakthrough With Potential Novo Nordisk Wegovy Deal (GuruFocus.com)
08:46AM	HIMS Q3 Deep Dive: Personalized Offerings and Strategic Expansion Shape Telehealth Growth (StockStory)
06:41AM	Hims Shares Rise on Talks to Offer Novos New Obesity Pill (Bloomberg)
12:04AM	Hims & Hers Health Inc (HIMS) Q3 2025 Earnings Call Highlights: Robust Revenue Growth and ... (GuruFocus.com)
Nov-03-25 11:14PM	Analyst Report: Hims & Hers Health, Inc. (Morningstar Research)
06:23PM	Novo Nordisk's Wegovy could soon have a new sales outlet in the U.S. (MarketWatch)
05:47PM	Hims Says It's Negotiating A New Deal With Novo Nordisk; Shares Surge (Investor's Business Daily)
05:45PM	Hims & Hers Health, Inc. (HIMS) Q3 Earnings Match Estimates (Zacks)
05:38PM	Hims & Hers Health Third-Quarter Revenue Jumps as Subscribers Grow (The Wall Street Journal)
05:31PM	Hims and Hers revenue tops estimates amid jump in subscriber growth (Investing.com)
04:32PM	Earnings live: Palantir stock rises modestly on strong results, Hims & Hers stock surges (Yahoo Finance)
04:24PM	Hims & Hers Health's (NYSE:HIMS) Q3 Sales Top Estimates (StockStory)
04:05PM	Hims & Hers Health, Inc. Reports Third Quarter 2025 Financial Results (Business Wire)
11:40AM	OMCL vs. HIMS: Which Stock Should Value Investors Buy Now? (Zacks)
11:26AM	Stock Market Today: Palantir, Vertex, and Hims & Hers Report After the Closing Bell (TheStreet)
Nov-02-25 07:40AM	Fed fallout, missing jobs numbers, and a busy earnings calendar: What to watch this week (Yahoo Finance)
05:30AM	Why Pfizer Can Still Prevail in the Obesity Fight With Novo Nordisk (The Wall Street Journal)
Nov-01-25 11:07PM	Hims & Hers Health (HIMS) Q3 Earnings: What To Expect (StockStory)
Oct-31-25 03:20PM	Why Hims & Hers Health (HIMS) Stock Is Trading Up Today (StockStory)
01:58PM	Hims & Hers Scales AI-Driven Personalized Health and Wellness (Zacks)
10:09AM	Hims & Hers Q3 Preview: Growth Faces a Confidence Test (GuruFocus.com)
Oct-29-25 01:39PM	Can Sustained Product Demand Drive HIMS Stock Before Q3 Earnings? (Zacks)
10:00AM	Analysts Estimate Nyxoah SA (NYXH) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-28-25 05:45PM	Hims & Hers Health, Inc. (HIMS) Stock Dips While Market Gains: Key Facts (Zacks)
Oct-27-25 01:50PM	HIMS vs. LFMD: Which Telehealth Stock Is the Better Investment Now? (Zacks)
10:00AM	Hims & Hers Health, Inc. (HIMS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-24-25 06:35PM	Hims & Hers Short Interest Nears All-Time High, Buy The Dip? (MarketBeat)
12:35PM	Wall Street Resumes Winning Ways on CPI, Earnings Optimism (Schaeffer's Research)
10:00AM	Can steroids combat population collapse? The Enhanced Games wants to find out. (TechCrunch)
Oct-23-25 12:14PM	Telehealth Stock Could Rebound Off Long-Term Trendline (Schaeffer's Research)
12:31AM	1 Mid-Cap Stock Worth Your Attention and 2 We Avoid (StockStory)
Oct-22-25 08:12PM	Hims & Hers Health, Inc. (HIMS): A Bull Case Theory (Insider Monkey)
05:45PM	Why Hims & Hers Health, Inc. (HIMS) Dipped More Than Broader Market Today (Zacks)
05:25PM	Wall Street Wonders if Grail's Cancer Test Results Are a True Positive (Barrons.com)
10:40AM	Hims & Hers Advances AI-Powered Personalized Digital Healthcare (Zacks)
Oct-21-25 12:38PM	KeyBanc starts Hims & Hers with caution on margin (Investing.com)

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Perez Garcia Andrea G	Director	Dec 09 '25	Sale	39.17	2,500	97,925	80,166	Dec 10 04:35 PM
Perez Garcia Andrea G	Director	Dec 09 '25	Proposed Sale	39.17	2,500	97,925		Dec 09 10:07 AM
Boughton Soleil	Chief Legal Officer	Nov 24 '25	Sale	35.22	2,631	92,664	153,225	Nov 25 04:13 PM
Boughton Soleil	Officer	Nov 24 '25	Proposed Sale	35.11	2,631	92,374		Nov 24 10:03 AM
Okupe Oluyemi	Chief Financial Officer	Nov 17 '25	Option Exercise	7.15	23,187	165,817	93,419	Nov 19 04:31 PM
Okupe Oluyemi	Chief Financial Officer	Nov 17 '25	Sale	36.81	23,187	853,490	70,232	Nov 19 04:31 PM
Boughton Soleil	Chief Legal Officer	Nov 10 '25	Sale	42.53	2,637	112,152	155,856	Nov 12 08:02 PM
Boughton Soleil	Officer	Nov 10 '25	Proposed Sale	42.53	2,637	112,152		Nov 10 10:16 AM
Boughton Soleil	Chief Legal Officer	Oct 27 '25	Sale	50.10	2,637	132,114	158,493	Oct 28 04:23 PM
Boughton Soleil	Officer	Oct 27 '25	Proposed Sale	50.10	2,637	132,114		Oct 27 09:42 AM
Okupe Oluyemi	Chief Financial Officer	Oct 17 '25	Option Exercise	7.15	11,592	82,898	81,824	Oct 20 04:42 PM
Okupe Oluyemi	Chief Financial Officer	Oct 17 '25	Sale	57.13	11,592	662,222	70,232	Oct 20 04:42 PM
Dudum Andrew	Officer	Oct 16 '25	Proposed Sale	62.79	175,661	11,029,998		Oct 16 03:10 PM
Chi Michael	Chief Commercial Officer	Oct 10 '25	Option Exercise	6.82	900	6,138	292,339	Oct 14 04:17 PM
Chi Michael	Chief Commercial Officer	Oct 10 '25	Sale	58.25	900	52,425	291,439	Oct 14 04:17 PM
Boughton Soleil	Chief Legal Officer	Oct 13 '25	Sale	54.38	2,637	143,400	161,130	Oct 14 04:17 PM
Boughton Soleil	Officer	Oct 13 '25	Proposed Sale	54.38	2,637	143,400		Oct 14 06:47 AM
Chi Michael	Officer	Oct 10 '25	Proposed Sale	58.25	900	52,425		Oct 10 11:26 AM
Okupe Oluyemi	Chief Financial Officer	Oct 03 '25	Option Exercise	7.15	11,595	82,919	81,827	Oct 07 04:47 PM
Okupe Oluyemi	Chief Financial Officer	Oct 03 '25	Sale	57.72	11,595	669,232	70,232	Oct 07 04:47 PM
Chi Michael	Chief Commercial Officer	Oct 01 '25	Option Exercise	11.53	250	2,882	291,689	Oct 02 04:10 PM
Chi Michael	Chief Commercial Officer	Oct 01 '25	Sale	56.00	250	14,000	291,439	Oct 02 04:10 PM
Chi Michael	Officer	Oct 01 '25	Proposed Sale	56.00	250	14,000		Oct 01 11:34 AM
Okupe Oluyemi	Chief Financial Officer	Sep 29 '25	Option Exercise	5.01	49,832	249,658	155,232	Sep 30 04:33 PM
Okupe Oluyemi	Chief Financial Officer	Sep 29 '25	Sale	60.20	85,000	5,116,924	70,232	Sep 30 04:33 PM
Boughton Soleil	Chief Legal Officer	Sep 29 '25	Sale	58.79	2,637	155,029	163,767	Sep 30 04:33 PM
Boughton Soleil	Officer	Sep 29 '25	Proposed Sale	58.79	2,637	155,029		Sep 29 09:51 AM
Chi Michael	Chief Commercial Officer	Sep 24 '25	Option Exercise	5.01	2,100	10,521	293,539	Sep 25 06:06 PM
Chi Michael	Chief Commercial Officer	Sep 24 '25	Sale	56.52	2,100	118,692	291,439	Sep 25 06:06 PM
Okupe Oluyemi	Chief Financial Officer	Sep 22 '25	Sale	57.74	23,584	1,361,766	105,400	Sep 24 04:22 PM
Chi Michael	Officer	Sep 24 '25	Proposed Sale	56.52	2,100	118,692		Sep 24 11:02 AM
Oluyemi Okupe	Officer	Sep 22 '25	Proposed Sale	57.70	154,958	8,941,077		Sep 22 05:39 PM
Boughton Soleil	Chief Legal Officer	Sep 17 '25	Sale	50.50	2,637	133,168	166,404	Sep 19 04:28 PM
Carroll Patrick Harrison	Chief Medical Officer	Sep 17 '25	Sale	50.50	10,021	506,060	169,940	Sep 19 04:28 PM
Becklund Irene	PAO	Sep 17 '25	Sale	50.50	8,410	424,705	1,418	Sep 19 04:28 PM
Chi Michael	Chief Commercial Officer	Sep 17 '25	Sale	50.50	13,749	694,324	297,139	Sep 19 04:27 PM
Dudum Andrew	Chief Executive Officer	Sep 17 '25	Sale	50.57	65,110	3,292,906	95,315	Sep 19 04:27 PM
Chi Michael	Chief Commercial Officer	Sep 15 '25	Option Exercise	6.19	4,150	25,680	282,804	Sep 17 07:24 PM
Chi Michael	Chief Commercial Officer	Sep 15 '25	Sale	56.00	4,150	232,400	278,654	Sep 17 07:24 PM
Dudum Andrew	Chief Executive Officer	Sep 16 '25	Option Exercise	2.43	125,335	304,564	268,759	Sep 17 07:24 PM
Dudum Andrew	Chief Executive Officer	Sep 16 '25	Sale	53.48	128,127	6,852,300	160,425	Sep 17 07:24 PM
Dudum Andrew	Chief Executive Officer	Sep 16 '25	Sale	53.27	47,534	2,532,325	95,058	Sep 17 07:24 PM
Okupe Oluyemi	Chief Financial Officer	Sep 15 '25	Option Exercise	5.01	110,000	551,100	273,984	Sep 17 07:24 PM
Okupe Oluyemi	Chief Financial Officer	Sep 15 '25	Sale	55.35	145,000	8,026,076	128,984	Sep 17 07:24 PM
Dudum Andrew	Officer	Sep 17 '25	Proposed Sale	50.57	65,110	3,292,904		Sep 17 12:44 PM
Boughton Soleil	Officer	Sep 17 '25	Proposed Sale	50.50	2,637	133,168		Sep 17 11:15 AM
Carroll Patrick Harrison	Officer	Sep 17 '25	Proposed Sale	50.50	10,021	506,060		Sep 17 10:20 AM
Chi Michael	Officer	Sep 17 '25	Proposed Sale	50.50	13,749	694,324		Sep 17 10:07 AM
Becklund Irene	Officer	Sep 17 '25	Proposed Sale	50.50	8,410	424,705		Sep 17 09:50 AM
Dudum Andrew	Officer	Sep 16 '25	Proposed Sale	53.42	175,661	9,384,626		Sep 16 11:29 AM
Oluyemi Okupe	Officer	Sep 15 '25	Proposed Sale	53.96	145,000	7,824,200		Sep 15 06:35 PM
Chi Michael	Officer	Sep 15 '25	Proposed Sale	56.00	4,150	232,400		Sep 15 11:49 AM
Okupe Oluyemi	Chief Financial Officer	Aug 26 '25	Option Exercise	5.01	11,581	58,021	128,387	Aug 28 04:34 PM
Okupe Oluyemi	Chief Financial Officer	Aug 26 '25	Sale	43.69	11,581	505,968	116,806	Aug 28 04:34 PM
Boughton Soleil	Chief Legal Officer	Aug 25 '25	Sale	44.53	2,571	114,487	150,450	Aug 26 04:35 PM
Boughton Soleil	Officer	Aug 25 '25	Proposed Sale	44.53	2,571	114,487		Aug 25 09:46 AM
Dudum Andrew	Chief Executive Officer	Aug 18 '25	Option Exercise	2.43	125,335	304,564	197,855	Aug 20 04:14 PM
Dudum Andrew	Chief Executive Officer	Aug 18 '25	Sale	45.06	128,127	5,773,242	89,521	Aug 20 04:14 PM
Dudum Andrew	Chief Executive Officer	Aug 18 '25	Sale	45.05	47,534	2,141,492	142,592	Aug 20 04:14 PM
Dudum Andrew	Officer	Aug 18 '25	Proposed Sale	45.05	47,534	2,141,494		Aug 18 12:33 PM
Dudum Andrew	Officer	Aug 18 '25	Proposed Sale	45.22	128,127	5,793,903		Aug 18 10:22 AM
Okupe Oluyemi	Chief Financial Officer	Aug 13 '25	Option Exercise	5.01	11,581	58,021	65,665	Aug 15 04:18 PM
Okupe Oluyemi	Chief Financial Officer	Aug 13 '25	Sale	48.05	11,581	556,420	116,806	Aug 15 04:18 PM
Melissa Baird	Officer	Aug 12 '25	Proposed Sale	47.96	33,333	1,598,651		Aug 12 05:22 PM
Boughton Soleil	Chief Legal Officer	Aug 11 '25	Sale	51.64	2,572	132,818	153,021	Aug 12 04:33 PM
Dudum Andrew	Chief Executive Officer	Aug 07 '25	Sale	50.58	660,000	33,384,120	2,214,769	Aug 11 05:07 PM
Boughton Soleil	Officer	Aug 11 '25	Proposed Sale	51.64	2,572	132,818		Aug 11 10:18 AM
Carroll Patrick Harrison	Chief Medical Officer	Aug 06 '25	Sale	53.58	60,000	3,214,878	169,940	Aug 08 04:19 PM
Carroll Patrick Harrison	Officer	Aug 06 '25	Proposed Sale	53.58	60,000	3,214,881		Aug 06 01:27 PM
Chi Michael	Chief Commercial Officer	Jul 31 '25	Option Exercise	7.09	26,350	186,830	305,004	Aug 04 04:21 PM
Chi Michael	Chief Commercial Officer	Aug 01 '25	Option Exercise	11.53	250	2,882	278,904	Aug 04 04:21 PM
Chi Michael	Chief Commercial Officer	Jul 31 '25	Sale	67.00	26,350	1,765,450	278,654	Aug 04 04:21 PM
Chi Michael	Chief Commercial Officer	Aug 01 '25	Sale	64.44	250	16,110	278,654	Aug 04 04:21 PM
Chi Michael	Officer	Aug 01 '25	Proposed Sale	64.44	250	16,110		Aug 01 11:12 AM
Chi Michael	Officer	Jul 31 '25	Proposed Sale	67.00	26,350	1,765,450		Jul 31 11:02 AM
Boughton Soleil	Chief Legal Officer	Jul 28 '25	Sale	58.70	2,572	150,976	155,593	Jul 29 04:25 PM
Boughton Soleil	Officer	Jul 28 '25	Proposed Sale	58.70	2,572	150,976		Jul 28 12:59 PM
Chi Michael	Chief Commercial Officer	Jul 23 '25	Option Exercise	5.25	13,750	72,146	292,404	Jul 25 05:20 PM
Chi Michael	Chief Commercial Officer	Jul 24 '25	Option Exercise	5.01	2,100	10,521	280,754	Jul 25 05:20 PM
Chi Michael	Chief Commercial Officer	Jul 23 '25	Sale	56.00	13,750	770,000	278,654	Jul 25 05:20 PM
Chi Michael	Chief Commercial Officer	Jul 24 '25	Sale	57.52	2,100	120,792	278,654	Jul 25 05:20 PM
Chi Michael	Officer	Jul 24 '25	Proposed Sale	57.52	2,100	120,792		Jul 24 10:44 AM
Dudum Andrew	Chief Executive Officer	Jul 21 '25	Option Exercise	2.43	125,335	304,564	142,313	Jul 23 04:12 PM
Dudum Andrew	Chief Executive Officer	Jul 21 '25	Sale	49.54	125,335	6,208,637	92,313	Jul 23 04:12 PM
Chi Michael	Officer	Jul 23 '25	Proposed Sale	56.00	13,750	770,000		Jul 23 12:19 PM
Melissa Baird	Officer	Jul 21 '25	Proposed Sale	47.60	33,333	1,586,651		Jul 21 04:59 PM
Dudum Andrew	Officer	Jul 21 '25	Proposed Sale	49.54	125,335	6,208,636		Jul 21 10:41 AM
Dudum Andrew	Chief Executive Officer	Jul 16 '25	Sale	50.25	47,534	2,388,817	190,126	Jul 18 04:29 PM
Dudum Andrew	Chief Executive Officer	Jul 16 '25	Sale	50.58	2,792	141,217	92,313	Jul 18 04:29 PM
Dudum Andrew	Officer	Jul 16 '25	Proposed Sale	50.27	50,326	2,530,033		Jul 16 11:49 AM
Boughton Soleil	Chief Legal Officer	Jul 14 '25	Sale	47.82	2,572	122,993	158,165	Jul 15 04:28 PM
Okupe Oluyemi	Chief Financial Officer	Jul 14 '25	Option Exercise	5.01	7,587	38,011	65,665	Jul 15 04:28 PM
Okupe Oluyemi	Chief Financial Officer	Jul 14 '25	Sale	47.70	11,581	552,418	54,084	Jul 15 04:28 PM
Boughton Soleil	Officer	Jul 14 '25	Proposed Sale	47.82	2,572	122,993		Jul 14 12:25 PM
Melissa Baird	Officer	Jul 08 '25	Proposed Sale	48.96	33,333	1,631,984		Jul 08 04:48 PM
Okupe Oluyemi	Chief Financial Officer	Jul 07 '25	Option Exercise	5.01	6,437	32,249	69,659	Jul 08 04:40 PM
Okupe Oluyemi	Chief Financial Officer	Jul 07 '25	Sale	46.67	11,581	540,498	58,078	Jul 08 04:40 PM
Boughton Soleil	Chief Legal Officer	Jun 30 '25	Sale	50.50	2,572	129,886	160,737	Jul 01 04:45 PM
Boughton Soleil	Officer	Jun 30 '25	Proposed Sale	50.50	2,572	129,886		Jun 30 10:56 AM
Okupe Oluyemi	Chief Financial Officer	Jun 23 '25	Sale	47.25	23,107	1,091,766	63,222	Jun 24 04:31 PM

Open in Screener

TOI

Oncology Institute Inc

Dec 12 • 04:00PM ET

3.78

+0.02 0.53 %

Healthcare • Medical Care Facilities • USA • NASD

TOI Oncology Institute Inc daily Stock Chart

Peers: AMGN BMY PFE MRK LLY AZN GILD REGN VRTX BIIB

| Held by: VTI IWM VXF IWO VFMO VTWO IWC VTWG GSSC RSSL

Index	RUT	P/E	-	EPS (ttm)	-0.64	Insider Own	29.24%	Shs Outstand	97.57M	Perf Week	24.75%
Market Cap	371.88M	Forward P/E	-	EPS next Y	-0.32	Insider Trans	-19.05%	Shs Float	69.61M	Perf Month	10.20%
Enterprise Value	447.77M	PEG	-	EPS next Q	-0.09	Inst Own	31.17%	Short Float	9.44%	Perf Quarter	21.15%
Income	-54.66M	P/S	0.81	EPS this Y	17.25%	Inst Trans	3.46%	Short Ratio	2.87	Perf Half Y	53.04%
Sales	461.04M	P/B	-	EPS next Y	46.38%	ROA	-31.89%	Short Interest	6.57M	Perf YTD	1123.30%
Book/sh	-0.13	P/C	13.44	EPS next 5Y	46.29%	ROE	-3407.86%	52W High	4.88 -22.54%	Perf Year	1618.18%
Cash/sh	0.28	P/FCF	-	EPS past 3/5Y	-62.37% -	ROIC	-64.98%	52W Low	0.17 2115.71%	Perf 3Y	212.40%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	24.68% -	Gross Margin	13.29%	Volatility	7.43% 9.90%	Perf 5Y	-62.76%
Dividend TTM	-	EV/Sales	0.97	EPS Y/Y TTM	16.74%	Oper. Margin	-8.92%	ATR (14)	0.28	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.39	Sales Y/Y TTM	21.67%	Profit Margin	-11.86%	RSI (14)	58.23	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.68	EPS Q/Q	19.30%	SMA20	13.79%	Beta	0.19	Target Price	6.50
Payout	-	Debt/Eq	-	Sales Q/Q	36.70%	SMA50	0.75%	Rel Volume	1.01	Prev Close	3.76
Employees	825	LT Debt/Eq	-	Earnings	Nov 13 AMC	SMA200	28.63%	Avg Volume	2.29M	Price	3.78
IPO	Jun 04, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-23.57% 11.36%	Trades		Volume	2,317,177	Change	0.53%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-25-25	Initiated	Needham	Buy	$5
Jul-23-25	Initiated	Noble Capital Markets	Outperform	$8
Jul-16-25	Initiated	B. Riley Securities	Buy	$6
May-15-25	Initiated	BTIG Research	Buy	$7
Feb-26-24	Resumed	Jefferies	Buy	$2.50
Sep-14-22	Initiated	Guggenheim	Buy	$7
Aug-15-22	Initiated	Jefferies	Buy	$10

Dec-01-25 08:30AM	The Oncology Institute Announces Resignation of Board Member Gabe Ling (GlobeNewswire) -6.37%
Nov-21-25 05:20AM	A Mysterious Stock Has Rallied Over 950% This Year. Here's 1 Key Reason Why Investors Are Turning Bullish (Motley Fool)
Nov-14-25 12:06AM	The Oncology Institute Inc (TOI) Q3 2025 Earnings Call Highlights: Revenue Surge and AI ... (GuruFocus.com) +28.90%
Nov-13-25 05:30PM	The Oncology Institute, Inc. (TOI) Reports Q3 Loss, Beats Revenue Estimates (Zacks) -10.20%
04:05PM	The Oncology Institute Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance (GlobeNewswire)
04:04PM	Loading…
04:04PM	Ascertain and The Oncology Institute Co-Develop 'Touchless' AI Automation for Oncology Administration (GlobeNewswire)
Nov-12-25 06:25PM	Biorestorative Therapies, Inc. (BRTX) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
07:26AM	Earnings To Watch: The Oncology Institute Inc (TOI) Reports Q3 2025 Result (GuruFocus.com)
Nov-05-25 09:15AM	Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
Nov-04-25 05:50PM	CryoPort, Inc. (CYRX) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -5.57%
Oct-29-25 07:15AM	Avantor, Inc. (AVTR) Q3 Earnings and Revenues Miss Estimates (Zacks)
Oct-22-25 04:47PM	The Oncology Institute Announces Third Quarter 2025 Earnings Release Date and Conference Call (GlobeNewswire) +5.01%
Oct-21-25 09:45AM	This Healthcare Stock Is Up 1,000%, Outpacing Nvidia, Tesla, and Apple Combined (Motley Fool)
Oct-01-25 08:00AM	The Oncology Institute to Participate in the Noble Capital Markets Emerging Growth Virtual Equity Conference (GlobeNewswire)
Sep-29-25 08:00AM	The Oncology Institute Partners with Protocol Behavioral Health to Integrate Mental Health Services into Cancer Care (GlobeNewswire)
08:00AM	Loading…
Sep-22-25 08:00AM	The Oncology Institute Achieves $1.1 Million in Medicare Savings in CMS Enhancing Oncology Model Performance Period 2 through its California Professional Corporation (GlobeNewswire) +9.62%
Sep-18-25 09:35AM	The Oncology Institute (TOI) Loses 20% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks) +8.36%
Sep-02-25 04:05PM	The Oncology Institute Launches Lung Cancer Center of Excellence in Florida Led by International Oncology Expert Dr. Edgardo Santos (GlobeNewswire)
Aug-18-25 08:00AM	The Oncology Institute and Doctors Healthcare Plans Partner to Elevate Oncology Care Management in South Florida (GlobeNewswire) +7.45%
Aug-14-25 03:14AM	The Oncology Institute Inc (TOI) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com) -10.49%
Aug-13-25 04:05PM	The Oncology Institute Reports Second Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance (GlobeNewswire)
04:04PM	The Oncology Institute Announces Changes to Board of Directors (GlobeNewswire)
Jul-24-25 04:05PM	The Oncology Institute Announces Second Quarter 2025 Earnings Release Date and Conference Call (GlobeNewswire)
Jul-14-25 04:05PM	The Oncology Institute Names Kristin England as Chief Administrative Officer (GlobeNewswire) -7.48%
Jul-09-25 07:20AM	The Oncology Institute Becomes Exclusive Oncology Provider for 80,000+ SilverSummit Healthplan Medicaid Members (Insider Monkey)
Jun-30-25 04:05PM	The Oncology Institute and SilverSummit Healthplan Partner to Provide Oncology Care to Over 80,000 Medicaid Members in Nevada (GlobeNewswire) -6.39% +7.32%
Jun-03-25 08:00AM	The Oncology Institute set to join the Russell 2000 and Russell 3000 Indexes (GlobeNewswire)
May-14-25 04:06PM	The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance (GlobeNewswire) -10.57% +28.27%
04:05PM	The Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical Officer (GlobeNewswire)
May-13-25 07:08PM	Topicus.com Inc. Announces Election of Members of the Board of Directors (GlobeNewswire)
04:05PM	Loading…
04:05PM	The Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional Investor Conference (GlobeNewswire)
May-08-25 08:00AM	The Oncology Institute to Present at Upcoming ASCO Annual Meeting on High-Value Cancer Care Model Outcomes Showing Cost Savings and Lower Hospitalization Rates (GlobeNewswire) +6.18%
May-07-25 05:03PM	Constellation Software Inc. and Topicus.Com Inc. Announce Results for Topicus.com Inc. for the First Quarter Ended March 31, 2025 (GlobeNewswire) +5.36%
May-01-25 05:48PM	Topicus.com Inc. Defers Release Date for First Quarter Results (GlobeNewswire) +12.50%
Apr-30-25 06:04AM	Why The Oncology Institute, Inc. (TOI) is Surging in 2025 (Insider Monkey)
Apr-26-25 11:00AM	Microsoft, Apple Set To Report Earnings As Markets Watch Out For Core PCE Price Index (Seeking Alpha)
Apr-23-25 08:00AM	The Oncology Institute Announces First Quarter 2025 Earnings Release Date and Conference Call (GlobeNewswire) +6.27%
Apr-22-25 04:05PM	The Oncology Institute of Hope and Innovation Expands Research Partnership with Helios Clinical Across Markets, Enhancing Access to Cutting-Edge Cancer Trials (GlobeNewswire) +13.39%
Apr-01-25 10:04AM	The Oncology Institute, Inc. (TOI): Among Stocks Insiders Were Buying In Q1 2025 (Insider Monkey) +10.53%
Mar-31-25 08:00AM	TOI Launches Florida Oncology Network, a Fully Delegated Cancer Care Network, and Announces Four Additional Value-based Contracts in Q1 (GlobeNewswire)
Mar-26-25 03:02AM	The Oncology Institute Inc (TOI) Q4 2024 Earnings Call Highlights: Navigating Growth Amidst ... (GuruFocus.com)
Mar-25-25 06:28PM	The Oncology Institute, Inc. (TOI) Q4 2024 Earnings Call Transcript (SeekingAlpha)
Mar-24-25 09:05AM	Earnings To Watch: The Oncology Institute Inc (TOI) Reports Q4 2024 Result (GuruFocus.com) +24.47%
06:01AM	The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025 (GlobeNewswire)
06:00AM	The Oncology Institute Announces $16.5 million Private Placement (GlobeNewswire)
Mar-04-25 08:00AM	The Oncology Institute Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call (GlobeNewswire)
Feb-26-25 08:00AM	The Oncology Institute Announces Amendment to Facility Agreement and Debt Paydown (GlobeNewswire) +19.66%
Dec-18-24 04:05PM	Florida Blue enhances cancer care for thousands of members (GlobeNewswire) +11.12%
Nov-13-24 04:05PM	The Oncology Institute Reports Third Quarter 2024 Financial Results (GlobeNewswire) -9.03% -10.84%
Nov-11-24 08:00AM	The Oncology Institute Announces Certification to Administer Pluvicto Therapy in California (GlobeNewswire)
Nov-04-24 07:09PM	The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call (GlobeNewswire) -6.64%
Oct-23-24 08:00AM	The Oncology Institute Joins Lantern's Cancer Care Network of Excellence (GlobeNewswire)
Oct-14-24 08:00AM	The American Journal of Managed Care and The Oncology Institute to Co-Host Symposium for Value-Based Cancer Care (GlobeNewswire)
Sep-30-24 08:00AM	The Oncology Institute of Hope & Innovation Launches Oregon Market (GlobeNewswire) +5.59%
Sep-23-24 08:00AM	The Oncology Institute Announces CFO Transition (GlobeNewswire)
Aug-13-24 04:05PM	The Oncology Institute Reports Second Quarter 2024 Financial Results and Updates Full Year 2024 Guidance (GlobeNewswire) +13.40% -18.18%
Jul-23-24 08:00AM	The Oncology Institute Announces Second Quarter 2024 Earnings Release Date and Conference Call (GlobeNewswire)
May-29-24 08:00AM	The Oncology Institute to Participate at Upcoming Investor Conferences (GlobeNewswire)
May-22-24 08:00AM	The Oncology Institute Executives to Participate in Multiple Panel Presentations at APG 2024 Spring Conference (GlobeNewswire)
May-15-24 03:14AM	The Oncology Institute Inc (TOI) (Q1 2024) Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com) -24.00%
May-14-24 06:05PM	The Oncology Institute, Inc. (TOI) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:05PM	The Oncology Institute Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Guidance (GlobeNewswire)
May-07-24 04:05PM	The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit (GlobeNewswire) -6.08%
Apr-23-24 08:00AM	The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call (GlobeNewswire)
Apr-08-24 08:00AM	Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute (GlobeNewswire) +6.00%
Apr-04-24 08:00AM	The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California (GlobeNewswire)
Apr-01-24 01:35PM	The Oncology Institute, Inc. (NASDAQ:TOI) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-27-24 08:52PM	TOI Stock Earnings: The Oncology Institute Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace) +8.88% -14.13%
05:34PM	The Oncology Institute Inc (TOI) Reports Mixed Q4 and Full Year 2023 Results (GuruFocus.com)
04:05PM	The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024 (GlobeNewswire)
Mar-21-24 09:35AM	Down -23.64% in 4 Weeks, Here's Why The Oncology Institute (TOI) Looks Ripe for a Turnaround (Zacks)
Mar-14-24 08:09AM	MaxHealth & The Oncology Institute Expand Value-Based Care Partnership (GlobeNewswire) +5.62%
Mar-06-24 08:00AM	The Oncology Institute Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call (GlobeNewswire)
Feb-27-24 04:05PM	The Oncology Institute to Participate at Upcoming Investor Conferences (GlobeNewswire)
Feb-20-24 08:00AM	Carrum Health and The Oncology Institute Partner on Breast Cancer Treatment Model (GlobeNewswire)
Jan-25-24 08:00AM	WellBe Senior Medical Partners with The Oncology Institute to Extend High-Value Cancer Care Services Across Illinois and Ohio (GlobeNewswire)
Dec-04-23 08:00AM	The Oncology Institute Expands its Specialty Medication Business by Opening Pharmacy Operations in California (GlobeNewswire)
Nov-16-23 05:04AM	Insider Sell Alert: Director Brad Hively Sells 47,000 Shares of The Oncology Institute Inc (TOI) (GuruFocus.com) -7.21%
Nov-11-23 12:43PM	The Oncology Institute, Inc. (NASDAQ:TOI) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-08-23 05:50PM	The Oncology Institute Inc (TOI) Reports Q3 2023 Results: Revenue Up, Net Loss Widens (GuruFocus.com) +5.75% +27.72%
04:05PM	The Oncology Institute Reports Third Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance (GlobeNewswire)
Oct-18-23 08:03AM	The Oncology Institute Announces Third Quarter 2023 Earnings Release Date and Conference Call (GlobeNewswire)
Oct-11-23 04:05PM	The Oncology Institute Names Jeremy Castle as Chief Operations Officer (GlobeNewswire)
Sep-26-23 04:05PM	The Oncology Institute Executive Leaders to Present at the 2023 Association for Value-Based Cancer Care (AVBCC) Summit (GlobeNewswire)
Sep-18-23 08:00AM	The Oncology Institute Regains Compliance with Nasdaq Listing Requirements (GlobeNewswire)
Aug-09-23 08:10AM	Ambience Healthcare and The Oncology Institute (TOI) Partner to Create a Best-in-Class Oncology Experience for Patients and Clinicians, Leveraging Breakthrough Generative AI Technology (GlobeNewswire)
Aug-08-23 04:40PM	The Oncology Institute Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance (GlobeNewswire)
Aug-02-23 06:16AM	Oncology Institute (NASDAQ:TOI) shareholders have endured a 90% loss from investing in the stock three years ago (Simply Wall St.) -5.71%
Jul-31-23 08:00AM	The Oncology Institute Partners with House Rx to Accelerate Growth of Pharmacy Operations (GlobeNewswire)
Jul-18-23 08:00AM	The Oncology Institute Announces Second Quarter 2023 Earnings Release Date and Conference Call (GlobeNewswire)
Jun-12-23 06:00AM	The Oncology Institute Announces Leadership Transition (GlobeNewswire) -9.02%
Jun-09-23 08:00AM	The Oncology Institute (TOI) and Massive Bio Forge Partnership to Revolutionize Cancer Care and AI-enabled Cancer Research (GlobeNewswire) -5.31%
Jun-07-23 08:00AM	The Oncology Institute to Open Project Southland (GlobeNewswire) +17.07%
May-31-23 08:01AM	The Oncology Institute Featured on Four Abstracts at ASCO 2023 Annual Meeting (GlobeNewswire)
08:00AM	The Oncology Institute to Participate at Upcoming Investor Conferences (GlobeNewswire)
May-10-23 04:05PM	The Oncology Institute Reports First Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance (GlobeNewswire)
May-04-23 11:47AM	The Oncology Institute Announces a Strategic Partnership with IDEOlogy Health to Provide Customized Medical Education (PR Newswire)
May-02-23 08:00AM	TOI Patient is First Worldwide to be Treated with Promising Therapy for Metastatic Ovarian Cancer (GlobeNewswire) -6.51%
Apr-19-23 08:00AM	The Oncology Institute Announces First Quarter 2023 Earnings Release Date and Conference Call (GlobeNewswire)
Mar-16-23 08:08PM	CORRECTION -- The Oncology Institute Reports Updated Fourth Quarter and Full Year 2022 Financial Results and Guidance for 2023 (GlobeNewswire) -12.41% -17.07%

The Oncology Institute, Inc. provides cancer care treatment services. It operates through the following business segments: Dispensary, Patient Care, and Clinical Trials and Other. The company was founded in 2007 and is headquartered in Cerritos, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Pacala Mark L	Director	Nov 18 '25	Sale	4.00	50,000	200,000	174,971	Nov 20 04:55 PM
MARK PACALA	Director	Nov 18 '25	Proposed Sale	4.00	50,000	200,000		Nov 18 04:05 PM
M33 Growth I L.P.	Director	Sep 04 '25	Sale	3.09	6,018,168	18,596,139	7,932,389	Sep 05 06:12 AM
M33 Growth I L.P.	Director	Sep 04 '25	Sale	3.09	681,832	2,106,861	590,892	Sep 05 06:12 AM
Hively Brad	Director	Aug 19 '25	Sale	4.06	20,221	82,097	622,980	Aug 21 03:13 PM
M33 Growth I L.P.	Director	Jun 05 '25	Sale	3.05	673,676	2,054,712	13,950,557	Jun 09 04:15 PM
M33 Growth I L.P.	Director	Jun 05 '25	Sale	3.05	76,324	232,788	1,272,724	Jun 09 04:15 PM
Hively Brad	Director	Jun 03 '25	Option Exercise	0.90	1,867,605	1,682,524	2,579,638	Jun 05 06:51 PM
Hively Brad	Director	Jun 03 '25	Sale	2.87	1,976,137	5,672,106	603,501	Jun 05 06:51 PM
TOI M, LLC	10% Owner	Jun 05 '25	Proposed Sale	3.20	127,207	407,062		Jun 05 06:17 PM
M33 Growth I L.P.	10% Owner	Jun 05 '25	Proposed Sale	3.20	1,122,793	3,592,938		Jun 05 06:13 PM
BRADFORD DANIEL HIVELY	Director	Jun 03 '25	Proposed Sale	2.87	39,600	113,652		Jun 03 05:08 PM
BRADFORD DANIEL HIVELY	Director	Jun 03 '25	Proposed Sale	2.87	1,936,537	5,557,861		Jun 03 04:27 PM
M33 Growth I L.P.	Director	May 20 '25	Sale	2.71	1,796,468	4,873,638	14,624,233	May 22 07:38 PM
M33 Growth I L.P.	Director	May 20 '25	Sale	2.71	203,532	552,162	1,349,048	May 22 07:38 PM
TOI M, LLC	10% Owner	May 20 '25	Proposed Sale	3.06	203,532	622,808		May 20 06:25 PM
M33 Growth I L.P.	10% Owner	May 20 '25	Proposed Sale	3.06	1,796,468	5,497,192		May 20 06:19 PM
Virnich Daniel	Chief Executive Officer	Mar 26 '25	Buy	1.04	22,640	23,584	724,363	Mar 28 05:50 PM
Podnos Yale	Chief Medical Officer	Mar 26 '25	Buy	1.04	9,056	9,434	79,049	Mar 28 05:48 PM
Pacala Mark L	Director	Mar 26 '25	Buy	1.04	90,562	94,338	224,971	Mar 28 05:41 PM
Johnson Karen Marie	Director	Mar 26 '25	Buy	1.04	36,224	37,735	203,409	Mar 28 05:36 PM
Hively Brad	Director	Mar 26 '25	Buy	1.04	9,056	9,434	675,809	Mar 28 05:34 PM
Castle Jeremy	Chief Operating Officer	Mar 26 '25	Buy	1.04	9,056	9,434	90,386	Mar 28 05:33 PM
Carter Robert Ross	Chief Financial Officer	Mar 26 '25	Buy	1.04	9,056	9,434	39,407	Mar 28 05:27 PM
BARASCH RICHARD A	Director	Mar 26 '25	Buy	1.04	1,358,448	1,415,095	1,775,641	Mar 28 05:25 PM

Open in Screener

AIRS

Airsculpt Technologies Inc

Dec 12 • 04:00PM ET

2.60

-0.44 -14.47 %

Healthcare • Medical Care Facilities • USA • NASD

AIRS Airsculpt Technologies Inc daily Stock Chart

Peers: LGVN DERM HROW VRCA PMVP RCEL TVRD DBVT BKD CDTX

| Held by: VTI VXF IWM VTWO VFMO IWO SCHA VFMF IWC IWN

Index	RUT	P/E	-	EPS (ttm)	-0.30	Insider Own	76.04%	Shs Outstand	62.44M	Perf Week	-14.47%
Market Cap	162.34M	Forward P/E	-	EPS next Y	-0.07	Insider Trans	0.00%	Shs Float	14.96M	Perf Month	-57.38%
Enterprise Value	243.01M	PEG	-	EPS next Q	-0.03	Inst Own	29.41%	Short Float	32.11%	Perf Quarter	-56.16%
Income	-17.98M	P/S	1.03	EPS this Y	-865.00%	Inst Trans	2.91%	Short Ratio	3.99	Perf Half Y	-42.86%
Sales	157.55M	P/B	1.98	EPS next Y	57.19%	ROA	-9.13%	Short Interest	4.80M	Perf YTD	-49.90%
Book/sh	1.32	P/C	30.01	EPS next 5Y	-	ROE	-21.85%	52W High	12.00 -78.33%	Perf Year	-60.12%
Cash/sh	0.09	P/FCF	65.72	EPS past 3/5Y	-172.08% -29.15%	ROIC	-11.59%	52W Low	1.53 69.93%	Perf 3Y	-19.25%
Dividend Est.	-	EV/EBITDA	28.16	Sales past 3/5Y	10.60% 34.33%	Gross Margin	50.71%	Volatility	12.89% 12.96%	Perf 5Y	-
Dividend TTM	-	EV/Sales	1.54	EPS Y/Y TTM	-119.56%	Oper. Margin	-2.71%	ATR (14)	0.54	Perf 10Y	-
Dividend Ex-Date	Aug 25, 2022	Quick Ratio	0.51	Sales Y/Y TTM	-16.54%	Profit Margin	-11.41%	RSI (14)	26.22	Recom	2.33
Dividend Gr. 3/5Y	- -	Current Ratio	0.51	EPS Q/Q	-45.42%	SMA20	-26.38%	Beta	2.64	Target Price	6.50
Payout	-	Debt/Eq	1.05	Sales Q/Q	-17.76%	SMA50	-62.45%	Rel Volume	0.69	Prev Close	3.04
Employees	389	LT Debt/Eq	0.89	Earnings	Nov 07 BMO	SMA200	-49.84%	Avg Volume	1.20M	Price	2.60
IPO	Oct 29, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	-100.00% -12.07%	Trades		Volume	834,117	Change	-14.47%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-17-24	Initiated	BTIG Research	Neutral
May-14-24	Downgrade	Leerink Partners	Outperform → Market Perform	$8.25 → $5
Nov-11-22	Downgrade	Piper Sandler	Overweight → Neutral	$4
Jun-16-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$17 → $8.50
Nov-23-21	Initiated	SVB Leerink	Outperform	$26
Nov-23-21	Initiated	Raymond James	Outperform	$18
Nov-23-21	Initiated	Piper Sandler	Overweight	$22
Nov-23-21	Initiated	Morgan Stanley	Overweight	$17

Nov-17-25 05:32PM	AirSculpt Technologies Appoints Mike Doyle as Non-Executive Chairman of the Board (GlobeNewswire) -23.77%
Nov-07-25 07:15AM	AirSculpt Technologies, Inc. (AIRS) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -41.66%
06:00AM	AirSculpt Technologies Reports Third Quarter Fiscal 2025 Results (GlobeNewswire)
Nov-06-25 07:24AM	What To Expect From AirSculpt Technologies Inc (AIRS) Q3 2025 Earnings (GuruFocus.com) +9.16%
Nov-05-25 06:25PM	Xperi (XPER) Q3 Earnings and Revenues Top Estimates (Zacks) +6.78%
06:45AM	Loading…
Oct-31-25 06:45AM	AirSculpt Technologies Announces Third Quarter Fiscal 2025 Earnings Release Date and Conference Call (GlobeNewswire)
Oct-23-25 11:10AM	This Stock Makes You Look Good and It Just Hit New 3-Year Highs (Barchart)
Sep-26-25 09:40AM	Are Business Services Stocks Lagging AirSculpt Technologies (AIRS) This Year? (Zacks)
Sep-19-25 12:00PM	Are You Looking for a Top Momentum Pick? Why AirSculpt Technologies, Inc. (AIRS) is a Great Choice (Zacks) +6.50%
Sep-03-25 12:00PM	AirSculpt Technologies (AIRS) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Aug-19-25 08:00AM	Sidoti Events, LLC's Virtual August Micro-Cap Conference (ACCESSWIRE)
Aug-13-25 06:00AM	AirSculpt Technologies Announces Participation in Sidoti Micro Cap Conference (GlobeNewswire) +8.79%
Aug-08-25 09:40AM	Is AirSculpt Technologies (AIRS) Stock Outpacing Its Business Services Peers This Year? (Zacks)
Aug-02-25 03:07AM	AirSculpt Technologies Inc (AIRS) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
Aug-01-25 07:10AM	AirSculpt Technologies, Inc. (AIRS) Q2 Earnings Match Estimates (Zacks) -10.51%
06:00AM	Loading…
06:00AM	AirSculpt Technologies Reports Second Quarter Fiscal 2025 Results (GlobeNewswire)
Jul-31-25 09:30AM	Earnings To Watch: AirSculpt Technologies Inc (AIRS) Reports Q2 2025 Result (GuruFocus.com) +7.65%
Jul-25-25 06:45AM	AirSculpt Technologies Announces Second Quarter Fiscal 2025 Earnings Release Date and Conference Call (GlobeNewswire)
Jul-02-25 02:39PM	AirSculpt Technologies (AIRS) Moves 8.7% Higher: Will This Strength Last? (Zacks)
Jun-16-25 06:45AM	AirSculpt Strengthens Balance Sheet with $10.0 Million Debt Paydown (GlobeNewswire) +11.21%
Jun-11-25 04:05PM	AirSculpt Announces Closing of Offering of Common Stock and Underwriters' Full Exercise of Option to Purchase Additional Shares (GlobeNewswire)
Jun-10-25 06:55AM	AirSculpt Announces Pricing of Offering of Common Stock (GlobeNewswire)
Jun-09-25 04:25PM	AirSculpt Announces Public Offering of Common Stock (GlobeNewswire)
May-27-25 12:00PM	AirSculpt Technologies, Inc. (AIRS) is a Great Momentum Stock: Should You Buy? (Zacks)
May-03-25 03:02AM	AirSculpt Technologies Inc (AIRS) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
May-02-25 11:02PM	Q1 2025 AirSculpt Technologies Inc Earnings Call (Thomson Reuters StreetEvents) +33.63% -19.54%
01:12PM	AirSculpt Technologies, Inc. (AIRS) Q1 2025 Earnings Call Transcript (Seeking Alpha)
07:10AM	AirSculpt Technologies, Inc. (AIRS) Reports Q1 Loss (Zacks)
06:00AM	AirSculpt Technologies Reports First Quarter Fiscal 2025 Results and Full Year Guidance (GlobeNewswire)
May-01-25 09:32AM	What To Expect From AirSculpt Technologies Inc (AIRS) Q1 2025 Earnings (GuruFocus.com)
06:45AM	Loading…
Apr-25-25 06:45AM	AirSculpt Technologies Announces First Quarter Fiscal 2025 Earnings Release Date and Conference Call (GlobeNewswire) +7.69%
Apr-17-25 05:27AM	New Strong Sell Stocks for April 17th (Zacks) +6.92%
Apr-14-25 07:18AM	New Strong Sell Stocks for April 14th (Zacks)
Apr-02-25 06:07AM	New Strong Sell Stocks for April 2nd (Zacks)
Apr-01-25 12:16PM	AirSculpt Technologies price target lowered to $2.50 from $6.50 at Leerink (TipRanks) -8.14%
Mar-26-25 05:33AM	New Strong Sell Stocks for March 26th (Zacks)
Mar-24-25 05:29AM	New Strong Sell Stocks for March 24th (Zacks)
Mar-15-25 03:02AM	AirSculpt Technologies Inc (AIRS) Q4 2024 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
12:48AM	Q4 2024 Airsculpt Technologies Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-14-25 07:10AM	AirSculpt Technologies, Inc. (AIRS) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
06:00AM	AirSculpt Technologies Reports Fourth Quarter, and Full Year Fiscal 2024 Results (GlobeNewswire)
Mar-11-25 09:15AM	Unveiling AirSculpt Technologies (AIRS) Q4 Outlook: Wall Street Estimates for Key Metrics (Zacks) -11.45%
Mar-06-25 06:45AM	AirSculpt Technologies Announces Fourth Quarter Fiscal 2024 Earnings Release Date and Conference Call (GlobeNewswire)
Jan-13-25 06:45AM	AirSculpt Technologies Updates Fiscal Year 2024 Guidance in Advance of its Participation in the ICR Conference 2025 (GlobeNewswire) -19.90%
Jan-07-25 06:45AM	AirSculpt Technologies Announces Participation in the ICR Conference 2025 (GlobeNewswire)
Dec-17-24 06:45AM	AirSculpt Technologies Names Yogi Jashnani Chief Executive Officer (GlobeNewswire) +5.18%
Dec-10-24 10:42PM	Why Is AirSculpt Technologies Inc. (AIRS) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now? (Insider Monkey) -5.67%
Dec-02-24 01:22PM	AirSculpt Technologies, Inc. Announces Opening of Its New White Plains, NY Center (PR Newswire)
Nov-09-24 02:04AM	AirSculpt Technologies Inc (AIRS) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
01:34AM	Q3 2024 Airsculpt Technologies Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-08-24 09:30AM	AirSculpt Technologies (AIRS) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks) +20.72%
07:10AM	AirSculpt Technologies, Inc. (AIRS) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
06:00AM	AirSculpt Technologies Reports Third Quarter Fiscal 2024 Results (GlobeNewswire)
Nov-07-24 07:09AM	What To Expect From AirSculpt Technologies Inc (AIRS) Q3 2024 Earnings (GuruFocus.com) -6.14%
Nov-05-24 11:17AM	AirSculpt Technologies (AIRS) Moves 14.2% Higher: Will This Strength Last? (Zacks)
Oct-24-24 06:30AM	AirSculpt Technologies Announces Preliminary Third Quarter 2024 Revenue Results (GlobeNewswire) +5.26%
Oct-15-24 08:05AM	AirSculpt Technologies (AIRS) Surges 5.6%: Is This an Indication of Further Gains? (Zacks)
Oct-01-24 12:48PM	AirSculpt Technologies, Inc. Announces Opening of Its New Center in Birmingham, MI (PR Newswire) -6.31%
Sep-24-24 01:30PM	AirSculpt Technologies, Inc. Adds New Center In Deerfield, IL To Meet Chicago Market Demand (PR Newswire) +7.34%
Sep-19-24 08:32AM	Do Options Traders Know Something About AirSculpt Technologies (AIRS) Stock We Don't? (Zacks) +6.77%
Aug-23-24 08:30AM	Implied Volatility Surging for AirSculpt Technologies (AIRS) Stock Options (Zacks)
Aug-19-24 12:00PM	AirSculpt Technologies, Inc. Announces Opening of Its New Center in Columbus, OH (PR Newswire)
Aug-10-24 08:18AM	AirSculpt Technologies, Inc. (NASDAQ:AIRS) Q2 2024 Earnings Call Transcript (Insider Monkey)
Aug-09-24 10:52AM	AIRS Stock Earnings: AirSculpt Technologies Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace)
09:30AM	Here's What Key Metrics Tell Us About AirSculpt Technologies (AIRS) Q2 Earnings (Zacks)
07:25AM	AirSculpt Technologies, Inc. (AIRS) Q2 Earnings and Revenues Miss Estimates (Zacks)
06:33AM	AirSculpt Technologies, Inc. (AIRS): The Best Cosmetic Surgery and Aesthetics Stocks To Buy? (Insider Monkey)
06:10AM	AirSculpt Technologies Reports Second Quarter Fiscal 2024 Results (GlobeNewswire)
06:00AM	AirSculpt Technologies Announces Leadership Changes (GlobeNewswire)
Aug-07-24 09:15AM	Ahead of AirSculpt Technologies (AIRS) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics (Zacks)
Jul-25-24 06:45AM	AirSculpt Technologies Announces Second Quarter Fiscal 2024 Earnings Release Date and Conference Call (GlobeNewswire)
Jul-15-24 11:57AM	7 Short-Squeeze Stocks That Could Beat Down the Bears (InvestorPlace)
Jun-17-24 06:00AM	3 Short-Squeeze Stocks to Buy Before July for 20% Returns (InvestorPlace)
May-31-24 09:36AM	Do Options Traders Know Something About AirSculpt (AIRS) Stock We Don't? (Zacks)
May-24-24 09:55AM	Here's Why AirSculpt Technologies (AIRS) Could be Great Choice for a Bottom Fisher (Zacks)
09:35AM	Down -38.41% in 4 Weeks, Here's Why AirSculpt Technologies (AIRS) Looks Ripe for a Turnaround (Zacks)
May-13-24 03:06AM	AirSculpt Technologies Inc (AIRS) Q1 2024 Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com)
May-11-24 10:19AM	AirSculpt Technologies, Inc. (NASDAQ:AIRS) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-10-24 03:32PM	AirSculpt Technologies Inc (AIRS) Exceeds First Quarter Revenue Estimates with Strong Performance (GuruFocus.com) -12.06%
01:48PM	AirSculpt Technologies Shares Down After Q1 Adjusted Earnings Fall (MT Newswires)
10:53AM	AIRS Stock Earnings: AirSculpt Technologies Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
09:30AM	Compared to Estimates, AirSculpt Technologies (AIRS) Q1 Earnings: A Look at Key Metrics (Zacks)
07:15AM	AirSculpt Technologies, Inc. (AIRS) Lags Q1 Earnings and Revenue Estimates (Zacks)
06:00AM	AirSculpt Technologies Reports for First Quarter Earnings (GlobeNewswire)
May-08-24 09:15AM	Countdown to AirSculpt Technologies (AIRS) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS (Zacks)
Apr-30-24 07:00AM	AirSculpt Technologies Announces First Quarter 2024 Earnings Release Date and Conference Call (GlobeNewswire)
Apr-29-24 08:30AM	AirSculpt Relocates and Expands to New Location to Meet Market Demand (PR Newswire)
Mar-19-24 08:30AM	AirSculpt Announces Kristen Doute, Star of Bravo's The Valley As Latest AirSculpt Client (PR Newswire)
Mar-18-24 07:00AM	Bear of the Day: AirSculpt (AIRS) (Zacks)
Mar-12-24 03:59PM	Short-Squeeze Showdown: 3 Stocks Ready to Crush the Skeptics (InvestorPlace)
Mar-10-24 10:18AM	10 Botox Alternatives for Smoothing Wrinkles and Anti-Aging Treatment (Insider Monkey)
Mar-07-24 07:00AM	AirSculpt Technologies Announces Participation at BofA Securities Consumer and Retail Conference (GlobeNewswire)
Mar-04-24 08:30AM	AirSculpt Technologies, Inc. Expands Its Scottsdale Location (PR Newswire) -5.10%
Feb-29-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Chemours, Methanex, and AirSculpt and Encourages Investors to Contact the Firm (GlobeNewswire)
Feb-28-24 08:52AM	AirSculpt Technologies, Inc. (NASDAQ:AIRS) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-27-24 09:53PM	Q4 2023 Airsculpt Technologies Inc Earnings Call (Thomson Reuters StreetEvents)
09:30AM	Here's What Key Metrics Tell Us About AirSculpt Technologies, Inc. (AIRS) Q4 Earnings (Zacks)
07:10AM	AirSculpt Technologies, Inc. (AIRS) Q4 Earnings and Revenues Miss Estimates (Zacks)
06:36AM	AirSculpt Technologies Inc (AIRS) Reports Strong Revenue and EBITDA Growth in Q4 and Full Year 2023 (GuruFocus.com)
06:00AM	AirSculpt Technologies Reports Double Digit Revenue Growth for the Fourth Quarter and Full Year 2023 (GlobeNewswire)

AirSculpt Technologies, Inc. is a fat removal treatment under its brand, Elite Body Sculpture.. It provides custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure, producing dramatic results. The company was founded by Aaron J. Rollins in 2012 and is headquartered in Miami Beach, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Feinstein Adam T	Director	Jun 09 '25	Buy	4.00	1,000,000	4,000,000	14,038,819	Jun 11 05:06 PM
Rollins Aaron	Executive Chairman	May 19 '25	Buy	3.60	2,118	7,629	15,146,039	May 20 04:11 PM
Jashnani Yogesh	Chief Executive Officer	May 07 '25	Buy	2.65	7,000	18,532	464,879	May 07 05:56 PM

LFMD

LifeMD Inc

TDOC

Teladoc Health Inc

HIMS

Hims & Hers Health Inc

TOI

Oncology Institute Inc

AIRS

Airsculpt Technologies Inc

Upgrade your FINVIZ experience